Nothing Special   »   [go: up one dir, main page]

KR101798375B1 - Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device - Google Patents

Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device Download PDF

Info

Publication number
KR101798375B1
KR101798375B1 KR1020110003538A KR20110003538A KR101798375B1 KR 101798375 B1 KR101798375 B1 KR 101798375B1 KR 1020110003538 A KR1020110003538 A KR 1020110003538A KR 20110003538 A KR20110003538 A KR 20110003538A KR 101798375 B1 KR101798375 B1 KR 101798375B1
Authority
KR
South Korea
Prior art keywords
liquid crystal
solution
mol
dianhydride
diamine
Prior art date
Application number
KR1020110003538A
Other languages
Korean (ko)
Other versions
KR20110085891A (en
Inventor
유우코 이누카이
켄이치 이즈미
카츠히로 우치야마
타카히토 카토우
Original Assignee
제이에스알 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이에스알 가부시끼가이샤 filed Critical 제이에스알 가부시끼가이샤
Publication of KR20110085891A publication Critical patent/KR20110085891A/en
Application granted granted Critical
Publication of KR101798375B1 publication Critical patent/KR101798375B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1003Preparatory processes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/50Physical properties
    • C08G2261/53Physical properties liquid-crystalline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

(과제) 보존 안정성이 우수하여, 액정 표시 소자를 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능한 액정 배향막을 부여하는 액정 배향제를 제공하는 것이다.
(해결 수단) 상기 액정 배향제는, 테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서, 상기 테트라카본산 2무수물이, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을 전체 테트라카본산 2무수물에 대하여 5∼80몰% 함유하는 것이다.
Disclosed is a liquid crystal aligning agent which is excellent in storage stability and which can maintain a high quality display even when the liquid crystal display element is used for a long time.
(Solution) The liquid crystal aligning agent is a liquid crystal alignment liquid containing at least one polymer selected from the group consisting of a polyamic acid obtained by reacting a tetracarboxylic acid dianhydride with a diamine and a polyimide obtained by dehydrating and ring- Wherein the tetracarboxylic acid dianhydride is at least one selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride. And the species is contained in an amount of 5 to 80 mol% based on the total tetracarboxylic dianhydride.

Description

액정 배향제, 액정 배향막 및 액정 표시 소자 {LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE}TECHNICAL FIELD [0001] The present invention relates to a liquid crystal alignment material, a liquid crystal alignment film, and a liquid crystal display device,

본 발명은, 액정 배향제 및 액정 표시 소자에 관한 것이다. 더욱 상세하게는, 보존 안정성이 우수하고, 특히 내열성이 우수한 액정 배향제 및, 고품위의 표시가 가능하고, 열(熱)스트레스에 의한 표시 열화가 억제되어, 장시간 구동이 가능한 액정 표시 소자에 관한 것이다. The present invention relates to a liquid crystal aligning agent and a liquid crystal display element. More particularly, the present invention relates to a liquid crystal aligning agent excellent in storage stability, particularly excellent in heat resistance, and a liquid crystal display element capable of high-quality display, suppressed display deterioration due to thermal stress, and capable of driving for a long time .

액정 표시 소자에 이용되는 액정 배향막의 재료는, 폴리이미드, 폴리아미드, 폴리암산, 폴리에스테르 등의 수지 재료가 알려져 있다. 그 중에서도 폴리암산 또는 폴리이미드로 이루어지는 액정 배향막은 내열성, 기계적 강도, 액정과의 친화성 등이 우수하여, 많은 액정 표시 소자에 사용되고 있다(특허문헌 1∼6). As the material of the liquid crystal alignment film used in the liquid crystal display element, a resin material such as polyimide, polyamide, polyamic acid, polyester and the like is known. Among them, a liquid crystal alignment film made of polyamic acid or polyimide has excellent heat resistance, mechanical strength, affinity with liquid crystal, and is used in many liquid crystal display devices (Patent Documents 1 to 6).

이 중 폴리암산은, 범용의 유기 용매에 대한 용해성이 높기 때문에, 액정 표시 소자의 제조 공정에 있어서의 인쇄 공정이 용이한 액정 배향제를 얻을 수 있고, 그리고 수지 가격이 저렴하다는 이점이 있다. 그러나, 폴리암산으로 이루어지는 액정 배향막을 갖는 액정 표시 소자는 열스트레스에 취약하여, 액정 표시 소자를 장시간 구동했을 때에, 액정 배향막의 열화에 의한 전압 보전율의 저하가 문제가 되고 있다. 최근에는, 액정 텔레비전으로 대표되는 바와 같이 액정 표시 소자의 수명이 10년을 넘는 것을 전제로 설계된다. 그 때문에, 액정 표시 소자를 장시간 구동한 경우에도 고품위의 표시를 유지하기 위해 장시간 안정된 전압 보전율을 나타내는 것이 중요해져, 배향막의 내열 신뢰성의 향상이 급무가 되고 있다. 지금까지 알려져 있는 배향막의 내열 신뢰성(열스트레스 내성)을 향상하는 방법으로서는, 액정 배향제에 에폭시 화합물을 배합함으로써 액정 배향막의 화학적 안정성을 증가시키는 방법(특허문헌 7), 카본산을 갖는 모너머를 도입한 폴리암산을 적용함으로써 액정 배향막의 소성시에 분자 간 가교를 형성하여, 이에 따라 막의 안정성을 증가시키는 방법(특허문헌 8) 등이 제안되고 있다. 그러나, 이들 기술에 의하면, 소기의 성능을 발휘하기 위해서는 에폭시 화합물 또는 카본산을 다량으로 사용하는 것이 필요하고, 액정 배향막의 리워크성(액정 배향제의 인쇄 불량시의 도막 박리의 용이성), 러빙 내성 등이 손상되는 경우가 있어, 추가적인 개선을 요한다. Among them, the polyamic acid has a high solubility in a general-purpose organic solvent, so that a liquid crystal aligning agent which facilitates the printing process in the production process of the liquid crystal display element can be obtained, and the resin has an advantage that the cost is low. However, a liquid crystal display element having a liquid crystal alignment film made of polyamic acid is vulnerable to thermal stress, and when the liquid crystal display element is driven for a long time, the voltage holding rate is deteriorated due to deterioration of the liquid crystal alignment film. In recent years, as exemplified by a liquid crystal television, the liquid crystal display device is designed on the premise that the lifetime of the liquid crystal display device exceeds 10 years. Therefore, even when the liquid crystal display element is driven for a long time, it is important to exhibit a stable voltage holding ratio for a long period of time in order to maintain a high-quality display, and improvement of the heat resistance reliability of the orientation film is urgently required. As a method for improving the heat resistance reliability (heat stress resistance) of the alignment film so far known, there are a method of increasing the chemical stability of the liquid crystal alignment film by adding an epoxy compound to the liquid crystal aligning agent (Patent Document 7) A method of forming an intermolecular crosslink at the time of baking a liquid crystal alignment film by applying the introduced polyamic acid, thereby increasing the stability of the film (Patent Document 8), and the like have been proposed. However, according to these techniques, it is necessary to use a large amount of an epoxy compound or a carbonic acid in order to exhibit desired performance, and it is necessary to use a large amount of epoxy compound or carbonic acid in order to improve the reworkability (easiness of peeling of the coating film in printing failure of the liquid crystal aligning agent) Resistance and the like may be damaged, and further improvement is required.

한편 폴리이미드를 함유하는 액정 배향막은, 얻어지는 액정 배향막의 열스트레스 내성은 비교적 높기는 하지만, 종래 알려져 있는 폴리이미드는 범용의 유기 용매에 대한 용해성이 충분하지 않기 때문에, 액정 배향제의 보존 안정성에 문제를 발생시키는 경우가 있다. On the other hand, in the liquid crystal alignment film containing polyimide, although the obtained liquid crystal alignment film has a relatively high thermal stress resistance, the conventionally known polyimide has insufficient solubility in a general organic solvent, and therefore, problems in the storage stability of the liquid crystal aligning agent In some cases.

이러한 사정 하에, 범용의 유기 용매에 대하여 충분한 용해성을 갖고, 그리고 열스트레스 내성이 우수한 액정 배향막을 형성할 수 있는 폴리암산/폴리이미드계의 액정 배향제가 요구되고 있다. Under these circumstances, a polyamic acid / polyimide-based liquid crystal aligning agent capable of forming a liquid crystal alignment film having sufficient solubility in a general-purpose organic solvent and having excellent heat stress resistance is required.

그러나 최근, 사이클로헥산테트라카본산 무수물을 입체 선택적으로 제조하는 방법이 개발되어, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물을 각각 선택적으로 제조하는 것이 가능해졌다(특허문헌 9, 특허문헌 10 및 비특허문헌 1). 특허문헌 9 및 10에는, 테트라카본산 2무수물로서 상기의 부분입체이성질체(diastereomer)를 각각 100% 이용하여 합성된 폴리암산이 기재되어 있고, 이들이 충분히 높은 분자량을 갖는 폴리머라고 설명되어 있다. 그리고 상기 폴리암산이 액정 표시 소자의 액정 배향막 용도에 사용할 수 있는 것이 기재되어 있기는 하지만, 이들 문헌에 있어서는 액정 배향막의 특성은 하등 측정되어 있지 않고, 원료인 테트라카본산 2무수물의 구조와 얻어지는 액정 배향제의 보존 안정성 및 형성되는 액정 배향막의 열스트레스 내성과의 관련성에 대한 고찰은 전혀 이루어지고 있지 않다. Recently, however, a process for stereoselectively preparing cyclohexanetetracarboxylic acid anhydride has been developed, and 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid 2 (Patent Document 9, Patent Document 10, and Non-Patent Document 1). Patent Documents 9 and 10 describe a polyamic acid synthesized using tetracarboxylic acid dianhydrides each using 100% of the above diastereomers, which is described as a polymer having a sufficiently high molecular weight. Although it is described that the polyamic acid can be used for a liquid crystal alignment film of a liquid crystal display device, in these documents, the properties of the liquid crystal alignment film are not measured at all, and the structure of the tetracarboxylic acid dianhydride, There is no consideration as to the relationship between the storage stability of the alignment agent and the heat stress resistance of the formed liquid crystal alignment film.

일본공개특허공보 평4-153622호Japanese Patent Application Laid-Open No. 4-153622 일본공개특허공보 소60-107020호Japanese Patent Application Laid-Open No. 60-107020 일본공개특허공보 평11-258605호Japanese Patent Application Laid-Open No. 11-258605 일본공개특허공보 소56-91277호Japanese Laid-Open Patent Publication No. 56-91277 미국특허 제5,928,733호 명세서U.S. Patent No. 5,928,733 일본공개특허공보 소62-165628호Japanese Laid-Open Patent Publication No. 62-165628 일본공개특허공보 2008-299318호Japanese Patent Application Laid-Open No. 2008-299318 일본공개특허공보 2009-157351호Japanese Laid-Open Patent Publication No. 2009-157351 일본공개특허공보 2009-191253호JP-A-2009-191253 일본공개특허공보 2009-286706호Japanese Laid-Open Patent Publication No. 2009-286706 일본공개특허공보 평6-222366호Japanese Unexamined Patent Application Publication No. 6-222366 일본공개특허공보 평6-281937호Japanese Patent Application Laid-Open No. 6-281937 일본공개특허공보 평5-107544호Japanese Unexamined Patent Publication No. 5-107544 일본공개특허공보 2010-97188호Japanese Laid-Open Patent Publication No. 2010-97188

일본 고분자학회 예고(豫稿)집, 57권, 2호(2002) Journal of Polymer Society of Japan, Vol. 57, No. 2 (2002)

본 발명은, 상기의 사정을 감안하여 이루어진 것으로, 그 목적은, 보존 안정성이 우수하고, 액정 표시 소자를 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능한 액정 배향막을 부여하는 액정 배향제를 제공하는 것이다. The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a liquid crystal aligning agent which gives a liquid crystal alignment film which is excellent in storage stability and can maintain high quality display even when a liquid crystal display element is used for a long time will be.

본 발명의 다른 목적은, 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능한 액정 표시 소자를 제공하는 것이다. Another object of the present invention is to provide a liquid crystal display element capable of maintaining a high-quality display even when used for a long time.

본 발명의 또 다른 목적 및 이점은, 이하의 설명으로부터 분명해질 것이다. Other objects and advantages of the present invention will become apparent from the following description.

본 발명에 의하면, 본 발명의 상기 목적 및 이점은, 첫 번째로,According to the present invention, the above objects and advantages of the present invention are achieved by firstly,

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,1. A liquid crystal aligning agent comprising at least one polymer selected from the group consisting of a polyamic acid obtained by reacting a tetracarboxylic acid dianhydride with a diamine and a polyimide obtained by dehydrocondylating the polyamic acid,

상기 테트라카본산 2무수물이,Wherein the tetracarboxylic acid dianhydride is at least one selected from the group consisting of

1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함하는 상기 액정 배향제에 의해 달성된다. At least one selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride is added to the total tetracarboxylic dianhydride And 5 to 80 mol% of the liquid crystal aligning agent.

본 발명의 상기 목적 및 이점은, 두 번째로,The above objects and advantages of the present invention are secondly,

상기의 액정 배향제로 형성된 액정 배향막을 구비하는 액정 표시 소자에 의해 달성된다. And a liquid crystal alignment film formed of the above liquid crystal aligning agent.

본 발명의 액정 배향제는, 보존 안정성이 우수함과 함께, 액정 표시 소자에 이용했을 때에 이것을 장시간 가동시켜도 고품위의 표시를 지속하는 것이 가능한 액정 배향막을 부여한다. 따라서, 이러한 액정 배향제로 형성된 액정 배향막을 구비하는 본 발명의 액정 표시 소자는, 장시간 사용한 경우에도 고품위의 표시를 지속하는 것이 가능하다. The liquid crystal aligning agent of the present invention is excellent in storage stability and gives a liquid crystal alignment film capable of continuing high quality display even when it is used for a liquid crystal display element for a long time. Therefore, the liquid crystal display element of the present invention including the liquid crystal alignment film formed of such a liquid crystal aligning agent can continue the high-quality display even when used for a long time.

본 발명의 액정 표시 소자는 여러 가지 장치에 유효하게 적용할 수 있어, 예를 들면 시계, 휴대형 게임, 워드프로세서, 노트형 퍼스널 컴퓨터, 카 내비게이션 시스템, 캠코더, 휴대 정보 단말, 디지털 카메라, 휴대 전화, 각종 모니터, 액정 텔레비전 등의 표시 장치에 매우 적합하게 이용할 수 있다. The liquid crystal display device of the present invention can be effectively applied to various devices and can be used for various applications such as a clock, a portable game, a word processor, a notebook type personal computer, a car navigation system, a camcorder, a portable information terminal, It can be suitably used for display devices such as various monitors and liquid crystal televisions.

(발명을 실시하기 위한 형태)(Mode for carrying out the invention)

본 발명의 액정 배향제는,The liquid crystal aligning agent of the present invention,

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,1. A liquid crystal aligning agent comprising at least one polymer selected from the group consisting of a polyamic acid obtained by reacting a tetracarboxylic acid dianhydride with a diamine and a polyimide obtained by dehydrocondylating the polyamic acid,

상기 테트라카본산 2무수물이,Wherein the tetracarboxylic acid dianhydride is at least one selected from the group consisting of

1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함한다. At least one selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride is added to the total tetracarboxylic dianhydride 5 to 80 mol%.

이러한 특정의 테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를, 본 명세서 중에서 이하, 「특정 중합체」라고 하는 경우가 있다. At least one kind of polymer selected from the group consisting of a polyamic acid obtained by reacting such a specific tetracarboxylic acid dianhydride with a diamine and a polyimide obtained by dehydrocondylating the polyamic acid is referred to as a " .

<테트라카본산 2무수물>&Lt; Tetracarboxylic acid dianhydride >

본 발명에 있어서의 폴리암산을 합성하기 위한 테트라카본산 2무수물로서는, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종과 그 외의 테트라카본산 2무수물을 병용한다. Examples of the tetracarboxylic acid dianhydride for synthesizing the polyamic acid in the present invention include 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride And other tetracarboxylic acid dianhydrides are used in combination.

여기에서, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종의 전체 테트라카본산 무수물에 대한 사용 비율은 5∼80몰%이지만, 이것을 10∼60몰% 포함하는 것이 바람직하고, 15∼50몰% 포함하는 것이 더욱 바람직하다. 이 비율이 5몰% 미만인 경우에는 형성되는 액정 배향막의 내열 신뢰성이 떨어지는 경우가 있고, 한편 80몰%를 초과하는 경우에는 얻어지는 액정 배향막의 보존 안정성이 떨어지는 경우가 있기 때문에 바람직하지 않다. Here, at least one total tetracarboxylic anhydride selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid dianhydride and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride Is preferably 5 to 80 mol%, more preferably 10 to 60 mol%, further preferably 15 to 50 mol%. If the ratio is less than 5 mol%, the liquid crystal alignment film to be formed may have poor heat resistance reliability, while when it exceeds 80 mol%, the storage stability of the obtained liquid crystal alignment film may be poor, which is not preferable.

상기 테트라카본산 2무수물은, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물을 상기의 범위에서 포함하는 것이 보다 바람직하다. The tetracarboxylic acid dianhydride preferably contains 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride in the above-mentioned range.

상기 그 외의 테트라카본산 2무수물로서는, 예를 들면 지방족 테트라카본산 2무수물, 지환식 테트라카본산 2무수물, 방향족 테트라카본산 2무수물 등을 들 수 있다. 이들의 구체예로서는, 지방족 테트라카본산 2무수물로서, 예를 들면 부탄테트라카본산 2무수물 등을;Examples of other tetracarboxylic acid dianhydrides include aliphatic tetracarboxylic dianhydrides, alicyclic tetracarboxylic dianhydrides, aromatic tetracarboxylic dianhydrides, and the like. Specific examples thereof include aliphatic tetracarboxylic acid dianhydrides such as butanetetracarboxylic dianhydride;

지환식 테트라카본산 2무수물로서, 예를 들면 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물, 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온 등을; As the alicyclic tetracarboxylic acid dianhydride, for example, 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3a, 4, 5,9b-hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2- c] furan-1,3-dione, , 5,9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [ (Tetrahydrofuran-2 ', 5'-dione), 5- (2,5-dioxotetrahydro-3 ' 3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2: 3,5: 6-2 anhydride, 2,4,6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride, 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane- , 5,8,10-tetralone, and the like;

방향족 테트라카본산 2무수물로서, 예를 들면 피로멜리트산 2무수물 등을 각각 들 수 있는 것 외에,Examples of the aromatic tetracarboxylic acid dianhydride include pyromellitic dianhydride and the like,

특허문헌 14(일본공개특허공보 2010-97188호)에 기재된 테트라카본산 2무수물를 이용할 수 있다. Tetracarboxylic acid dianhydride described in Patent Document 14 (Japanese Patent Laid-Open No. 2010-97188) can be used.

상기 그 외의 테트라카본산 2무수물로서는, 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물 및 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온으로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 테트라카본산 2무수물」이라고 함)을 포함하는 것이 바람직하다. Examples of other tetracarboxylic acid dianhydrides include 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3a, 4,5, (Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5 , 9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [ (Tetrahydrofuran-2 &apos;, 5 ' -dione), 5- (2,5- dioxotetrahydro-3-fura Carboxymethylnorbornane-2: 3,5: 6-2 anhydride, 2, 3-cyclohexene-1,2-dicarboxylic anhydride, 4,6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride and 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane- , 8,10-tetraon (hereinafter, referred to as &quot; specific tetracarboxylic acid dianhydride &quot; To include yelling) is preferred.

상기 특정 테트라카본산 2무수물의 사용 비율은, 상기 그 외의 테트라카본산 2무수물 전체에 대하여, 50몰% 이상인 것이 바람직하고, 80몰% 이상인 것이 보다 바람직하고, 100몰%인 것이 특히 바람직하다. The use ratio of the specific tetracarboxylic acid dianhydride is preferably 50 mol% or more, more preferably 80 mol% or more, and particularly preferably 100 mol%, based on the total amount of the other tetracarboxylic dianhydrides.

<디아민> <Diamine>

본 발명에 있어서의 폴리암산을 합성하기 위해 이용되는 디아민으로서는, 예를 들면 지방족 디아민, 지환식 디아민, 방향족 디아민, 디아미노오르가노실록산 등을 들 수 있다. 이들의 구체예로서는, 지방족 디아민으로서, 예를 들면 1,1-메타자일릴렌디아민, 1,3-프로판디아민, 테트라메틸렌디아민, 펜타메틸렌디아민, 헥사메틸렌디아민 등을; Examples of the diamine used for synthesizing the polyamic acid in the present invention include aliphatic diamines, alicyclic diamines, aromatic diamines, diaminoorganosiloxanes and the like. Specific examples thereof include aliphatic diamines such as 1,1-meta-xylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine and the like;

지환식 디아민으로서, 예를 들면 1,4-디아미노사이클로헥산, 4,4'-메틸렌비스(사이클로헥실아민), 1,3-비스(아미노메틸)사이클로헥산 등을; As the alicyclic diamine, for example, 1,4-diaminocyclohexane, 4,4'-methylenebis (cyclohexylamine), 1,3-bis (aminomethyl) cyclohexane and the like;

방향족 디아민으로서, 예를 들면 p-페닐렌디아민, 4,4'-디아미노디페닐메탄, 4,4'-디아미노디페닐술피드, 4,4'-디아미노디페닐아민, 1,5-디아미노나프탈렌, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비 페닐, 2,7-디아미노플루오렌, 4,4'-디아미노디페닐에테르, 2,2-비스[4-(4-아미노페녹시)페닐]프로판, 9,9-비스(4-아미노페닐)플루오렌, 2,2-비스[4-(4-아미노페녹시) 페닐]헥사플루오로프로판, 2,2-비스(4-아미노페닐)헥사플루오로프로판, 4,4'-(p-페닐렌디이소프로필리덴)비스아닐린, 4,4'-(m-페닐렌디이소프로필리덴)비스아닐린, 1,4-비스(4-아미노페녹시)벤젠, 4,4'-비스(4-아미노페녹시)비페닐, 2,6-디아미노피리딘, 3,4-디아미노피리딘, 2,4-디아미노피리미딘, 3,6-디아미노아크리딘, 3,6-디아미노카르바졸, N-메틸-3,6-디아미노카르바졸, N-에틸-3,6-디아미노카르바졸, N-페닐-3,6-디아미노카르바졸, N,N'-비스(4-아미노페닐)-벤지딘, N,N'-비스(4-아미노페닐)-N,N'-디메틸벤지딘, 1,4-비스-(4-아미노페닐)-피페라진, 3,5-디아미노벤조산, 콜레스타닐옥시-3,5-디아미노벤젠, 콜레스테닐옥시-3,5-디아미노벤젠, 콜레스타닐옥시-2,4-디아미노벤젠, 콜레스테닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 콜레스타닐, 3,5-디아미노벤조산 콜레스테닐, 3,5-디아미노벤조산 라노스타닐, 3,6-비스(4-아미노벤조일옥시)콜레스탄, 3,6-비스(4-아미노페녹시)콜레스탄, 4-(4'-트리플루오로메톡시벤조일옥시)사이클로헥실-3,5-디아미노벤조에이트, 4-(4'-트리플루오로메틸벤조일옥시)사이클로헥실-3,5-디아미노벤조에이트, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-부틸사이클로헥산, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-헵틸사이클로헥산, 1,1-비스(4-((아미노페녹시)메틸)페닐)-4-헵틸사이클로헥산, 1,1-비스(4-((아미노페닐)메틸)페닐)-4-(4-헵틸사이클로헥실)사이클로헥산 및 하기식 (A-1):As the aromatic diamine, for example, p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylsulfide, 4,4'-diaminodiphenylamine, 1,5 Diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 2,7- Bis (4-aminophenoxy) phenyl] propane, 9,9-bis (4-aminophenyl) fluorene, 2, (4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 4,4 '- (p- phenylenediisopropylidene) Bis (4-aminophenoxy) benzene, 4,4'-bis (4-aminophenoxy) biphenyl, Diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacrylidine, 3,6-diaminocarbazole, - diaminocarbazole, N-ethyl-3, N, N'-bis (4-aminophenyl) -N, N'-diaminocarbazole, N-dimethylbenzidine, 1,4-bis- (4-aminophenyl) -piperazine, 3,5-diaminobenzoic acid, cholestanyloxy-3,5-diaminobenzene, cholestenyloxy- Diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestenyloxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid cholestanyl, 3,5-diaminobenzoic acid (4'-aminophenoxy) cholestane, 3, 6-bis (4-aminobenzoyloxy) cholestane, (Trifluoromethoxybenzoyloxy) cyclohexyl-3,5-diaminobenzoate, 4- (4'-trifluoromethylbenzoyloxy) cyclohexyl-3,5-diaminobenzoate, 1,1-bis (4 - ((aminophenyl) methyl) phenyl) -4-heptylcyclohexane, 1,1- Bis (4 - ((aminophenyl) methyl) phenyl) -4- (4-heptylcyclohexyl) cyclohexane, And the following formula (A-1):

Figure 112011002929345-pat00001
Figure 112011002929345-pat00001

(식 (A-1) 중, XI은 탄소수 1∼3의 알킬렌기, *-O-, *-COO- 또는 *-OCO-(단, 「*」을 붙인 결합손이 디아미노페닐기와 결합함)이고, a는 0 또는 1이고, b는 0∼2의 정수이고, c는 1∼20의 정수임) (Wherein (A-1) of, X I is an alkylene group, having a carbon number of 1~3 * -O-, * -COO- or * -OCO- (However, the bond attached to "*" hands are engaged with diamino group A is 0 or 1, b is an integer of 0 to 2, and c is an integer of 1 to 20)

로 나타나는 화합물 등을; And the like;

디아미노오르가노실록산으로서, 예를 들면 1,3-비스(3-아미노프로필)-테트라메틸디실록산 등을 각각 들 수 있는 것 외에,Examples of the diaminoorganosiloxane include 1,3-bis (3-aminopropyl) -tetramethyldisiloxane and the like,

특허문헌 14(일본공개특허공보 2010-97188호)에 기재된 디아민을 이용할 수 있다. Diamines described in Patent Document 14 (Japanese Patent Application Laid-Open No. 2010-97188) can be used.

상기식 (A-1)에 있어서의 XI은 탄소수 1∼3의 알킬렌기, *-O- 또는 *-COO-(단, 「*」을 붙인 결합손이 디아미노페닐기와 결합함)인 것이 바람직하다. 기 CcH2c+1-의 구체예로서는, 예를 들면 메틸기, 에틸기, n-프로필기, n-부틸기, n-펜틸기, n-헥실기, n-헵틸기, n-옥틸기, n-노닐기, n-데실기, n-도데실기, n-트리데실기, n-테트라데실기, n-펜타데실기, n-헥사데실기, n-헵타데실기, n-옥타데실기, n-노나데실기, n-에이코실기 등을 들 수 있다. 디아미노페닐기에 있어서의 2개의 아미노기는, 다른 기에 대하여 2,4-위치 또는 3,5-위치에 있는 것이 바람직하다. X I in the above formula (A-1) is an alkylene group having 1 to 3 carbon atoms, * -O- or * -COO- (provided that the bond with "*" is bonded to a diaminophenyl group) desirable. Specific examples of the group C c H 2c + 1 - include a methyl group, an ethyl group, a n-propyl group, an n-butyl group, an n-pentyl group, N-hexadecyl group, n-heptadecyl group, n-octadecyl group, n-hexadecyl group, n-hexadecyl group, an n-nonadecyl group, and an n-eicosyl group. The two amino groups in the diaminophenyl group are preferably in the 2,4-position or the 3,5-position with respect to the other groups.

상기식 (A-1)로 나타나는 화합물의 구체예로서는, 예를 들면 도데칸옥시-2,4-디아미노벤젠, 테트라데칸옥시-2,4-디아미노벤젠, 펜타데칸옥시-2,4-디아미노벤젠, 헥사데칸옥시-2,4-디아미노벤젠, 옥타데칸옥시-2,4-디아미노벤젠, 도데칸옥시-2,5-디아미노벤젠, 테트라데칸옥시-2,5-디아미노벤젠, 펜타데칸옥시-2,5-디아미노벤젠, 헥사데칸옥시-2,5-디아미노벤젠, 옥타데칸옥시-2,5-디아미노벤젠, 하기식 (A-1-1)∼(A-1-3):Specific examples of the compound represented by the formula (A-1) include dodecanoxy-2,4-diaminobenzene, tetradecanoxy-2,4-diaminobenzene, pentadecanoxy- Diaminobenzene, hexadecaneoxy-2,4-diaminobenzene, octadecanoxy-2,4-diaminobenzene, dodecaneoxy-2,5-diaminobenzene, tetradecanoxy-2,5-diaminobenzene Diaminobenzene, hexadecaneoxy-2,5-diaminobenzene, octadecanoxy-2,5-diaminobenzene, the following formulas (A-1-1) to (A- 1-3):

Figure 112011002929345-pat00002
Figure 112011002929345-pat00002

의 각각으로 나타나는 화합물 등을 들 수 있다. And the like.

상기식 (A-1)에 있어서, a 및 b는 동시에는 0이 되지 않는 것이 바람직하다. In the formula (A-1), it is preferable that a and b are not 0 at the same time.

상기 디아민은, p-페닐렌디아민, 3,5-디아미노벤조산, 4,4'-디아미노디페닐에테르, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비페닐, 4,4'-디아미노디페닐아민 및 4,4'-(m-페닐렌디이소프로필리덴)디아닐린으로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 디아민 1」이라고 함)을 포함하는 것이 바람직하다. Examples of the diamine include p-phenylenediamine, 3,5-diaminobenzoic acid, 4,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 2,2'- Diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 4,4'-diaminodiphenylamine and 4,4'- (Hereinafter referred to as &quot; specific diamine 1 &quot;) selected from the group consisting of ethylene diamine, propylene diamine, and diisopropylene dianiline.

또한, 본 발명의 액정 배향제가 수직 배향형(VA형)의 액정 표시 소자에 있어서의 액정 배향막의 형성에 이용되는 것인 경우에는, 상기와 같은 특정 디아민 외에, 콜레스타닐옥시-3,5-디아미노벤젠, 콜레스테닐옥시-3,5-디아미노벤젠, 콜레스타닐옥시-2,4-디아미노벤젠, 콜레스테닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 콜레스타닐, 3,5-디아미노벤조산 콜레스테닐, 3,5-디아미노벤조산 라노스타닐, 3,6-비스(4-아미노벤조일옥시)콜레스탄, 3,6-비스(4-아미노페녹시)콜레스탄 및 상기식 (A-1)로 나타나는 화합물로 이루어지는 군으로부터 선택되는 적어도 1종(이하, 「특정 디아민 2」라고 함)을 추가로 포함하는 것이 바람직하다. When the liquid crystal aligning agent of the present invention is used for forming a liquid crystal alignment film in a vertical alignment type (VA type) liquid crystal display device, in addition to the specific diamine as described above, cholestanyloxy- Diaminobenzene, cholestenyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestenyloxy-2,4-diaminobenzene, 3,5-diaminobenzoic acid Cholestanyl 3,5-diaminobenzoate, lanthanil 3,5-diaminobenzoate, 3,6-bis (4-aminobenzoyloxy) cholestane, 3,6-bis (Hereinafter referred to as &quot; specific diamine 2 &quot;) selected from the group consisting of a compound represented by the above formula (A-1) and a compound represented by the above formula (A-1).

본 발명의 액정 배향제가 VA형의 수직 배향형의 액정 표시 소자에 있어서의 액정 배향막의 형성에 이용되는 것인 경우, 상기 특정 디아민 1 및 특정 디아민 2의 전체 디아민에 대한 바람직한 사용 비율은 하기한 바와 같다. In the case where the liquid crystal aligning agent of the present invention is used for forming a liquid crystal alignment film in a vertical alignment type liquid crystal display element of the VA type, the preferred ratio of the specific diamine 1 and the specific diamine 2 to all diamines is same.

특정 디아민 1: 바람직하게는 20∼97%, 보다 바람직하게는 50∼95%, 특히 바람직하게는 60∼90% Specific diamine 1: preferably 20 to 97%, more preferably 50 to 95%, particularly preferably 60 to 90%

특정 디아민 2: 바람직하게는 3∼80몰%, 보다 바람직하게는 5∼50%, 특히 바람직하게는 10∼40% Specific diamine 2: preferably 3 to 80 mol%, more preferably 5 to 50%, particularly preferably 10 to 40%

이 경우, 상기 특정 디아민 1 및 특정 디아민 2의 합계의 사용 비율을, 전체 디아민에 대하여 100몰%로 하는 것이 바람직하다. In this case, it is preferable that the total use ratio of the specific diamine 1 and the specific diamine 2 is 100 mol% based on the total diamine.

한편, 본 발명의 액정 배향제가 VA형 이외의 액정 표시 소자(예를 들면 TN(Twisted Nematic)형, STN(Super Twisted Nematic)형, 횡전계 방식(예를 들면 IPS(In-Plane Switching), FFS(Fringe Field Switching) 등) 등)에 있어서의 액정 배향막의 형성에 이용되는 것인 경우, 상기 특정 디아민 1 및 특정 디아민 2의 전체 디아민에 대한 바람직한 사용 비율은 하기에 기재한 바와 같다. On the other hand, when the liquid crystal aligning agent of the present invention is applied to liquid crystal display devices other than the VA type (for example, TN (Twisted Nematic) type, STN (Super Twisted Nematic) type, (Fringe Field Switching), etc.)), the specific ratio of the specific diamine 1 and the specific diamine 2 to the total diamine is as described below.

특정 디아민 1: 바람직하게는 50몰% 이상, 보다 바람직하게는 80몰% 이상, 특히 바람직하게는 100몰% Specific diamine 1: preferably 50 mol% or more, more preferably 80 mol% or more, particularly preferably 100 mol%

특정 디아민 2: 바람직하게는 30몰% 이하, 보다 바람직하게는 10% 이하, 특히 바람직하게는 0몰% Specific diamine 2: preferably 30 mol% or less, more preferably 10% or less, particularly preferably 0 mol%

이 경우, 디아민으로서는, 상기 특정 디아민 1 및 특정 디아민 2의 합계를 100몰%로 하는 것이 바람직하고, 특정 디아민 1만을 사용하는 것이 보다 바람직하다. In this case, as the diamine, the total amount of the specific diamine 1 and the specific diamine 2 is preferably 100 mol%, more preferably only the specific diamine 1 is used.

<분자량 조절제> &Lt; Molecular weight regulator &

상기 폴리암산을 합성할 때에, 상기와 같은 테트라카본산 2무수물 및 디아민과 함께, 적당한 분자량 조절제를 이용하여 말단 수식형의 중합체를 합성해도 좋다. 폴리암산을 이러한 말단 수식형의 중합체로 함으로써, 당해 폴리암산 및 이것을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제는, 본 발명의 효과를 손상시키는 일 없이 그 도포성(인쇄성)이 더욱 향상된 것이 된다. In the synthesis of the polyamic acid, a terminal modifier type polymer may be synthesized by using a suitable molecular weight modifier together with the tetracarboxylic dianhydride and the diamine as described above. The liquid crystal aligning agent containing at least one polymer selected from the group consisting of the polyamic acid and the polyimide obtained by dehydration ring closure thereof by making the polyamic acid a polymer having such a terminal modification type is not capable of impairing the effect of the present invention (Printing property) is further improved.

상기 분자량 조절제로서는, 예를 들면 산 1무수물, 모노아민 화합물, 모노이소시아네이트 화합물 등을 들 수 있다. 이들의 구체예로서는, 산 1무수물로서는, 예를 들면 무수 말레산, 무수 프탈산, 무수 이타콘산, n-데실숙신산 무수물, n-도데실숙신산 무수물, n-테트라데실숙신산 무수물, n-헥사데실숙신산 무수물 등을; Examples of the molecular weight modifier include acid anhydrides, monoamine compounds, and monoisocyanate compounds. Specific examples thereof include acid anhydrides such as maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride, n-hexadecylsuccinic anhydride My back;

모노아민 화합물로서, 예를 들면 아닐린, 사이클로헥실아민, n-부틸아민, n-펜틸아민, n-헥실아민, n-헵틸아민, n-옥틸아민 등을; As the monoamine compound, for example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine and the like;

모노이소시아네이트 화합물로서, 예를 들면 페닐이소시아네이트, 나프틸이소시아네이트 등을 각각 들 수 있다. Examples of the monoisocyanate compound include phenyl isocyanate and naphthyl isocyanate.

분자량 조절제의 사용 비율은, 사용하는 테트라카본산 2무수물 및 디아민의 합계 100중량부에 대하여, 20중량부 이하로 하는 것이 바람직하고, 10중량부 이하로 하는 것이 보다 바람직하다. The use ratio of the molecular weight regulator is preferably 20 parts by weight or less, more preferably 10 parts by weight or less, based on 100 parts by weight of the total amount of tetracarboxylic acid dianhydride and diamine to be used.

<폴리암산의 합성> <Synthesis of polyamic acid>

폴리암산의 합성 반응에 제공되는 테트라카본산 2무수물과 디아민과의 사용 비율은, 디아민의 아미노기 1당량에 대하여, 테트라카본산 2무수물의 산 무수물기가 0.2∼2당량이 되는 비율이 바람직하고, 더욱 바람직하게는 0.3∼1.2당량이 되는 비율이다. The ratio of the tetracarboxylic acid dianhydride and the diamine to be used in the synthesis reaction of the polyamic acid is preferably such that the amount of the acid anhydride group of the tetracarboxylic acid dianhydride is from 0.2 to 2 equivalents based on 1 equivalent of the amino group of the diamine, Preferably 0.3 to 1.2 equivalents.

폴리암산의 합성 반응은, 바람직하게는 유기 용매 중에 있어서, 바람직하게는 -20℃∼150℃, 보다 바람직하게는 0∼100℃에서, 바람직하게는 0.1∼24시간, 보다 바람직하게는 0.5∼12시간 행해진다. The synthesis reaction of the polyamic acid is preferably carried out in an organic solvent at a temperature of preferably -20 ° C to 150 ° C, more preferably 0 to 100 ° C, preferably 0.1 to 24 hours, more preferably 0.5 to 12 hours Time is done.

여기에서, 유기 용매로서는, 예를 들면 비(非)프로톤성 극성 용매, 페놀 및 그 유도체, 알코올, 케톤, 에스테르, 에테르, 할로겐화 탄화 수소, 탄화 수소 등을 들 수 있다. Examples of the organic solvent include non-protic polar solvents, phenol and derivatives thereof, alcohols, ketones, esters, ethers, halogenated hydrocarbons and hydrocarbons.

이들 유기 용매의 구체예로서는, 상기 비프로톤성 극성 용매로서, 예를 들면 N-메틸-2-피롤리돈, N,N-디메틸아세트아미드, N,N-디메틸포름아미드, 디메틸술폭사이드, γ-부티로락톤, 테트라메틸요소, 헥사메틸포스포르트리아미드 등을; Specific examples of these organic solvents include non-protonic polar solvents such as N-methyl-2-pyrrolidone, N, N-dimethylacetamide, N, N-dimethylformamide, Butyrolactone, tetramethyl urea, hexamethylphosphoric triamide and the like;

상기 페놀 유도체로서, 예를 들면 m-크레졸, 자일레놀, 할로겐화 페놀 등을; As the phenol derivative, for example, m-cresol, xylenol, halogenated phenol and the like;

상기 알코올로서, 예를 들면 메틸알코올, 에틸알코올, 이소프로필알코올, 사이클로헥산올, 에틸렌글리콜, 프로필렌글리콜, 1,4-부탄디올, 트리에틸렌글리콜, 에틸렌글리콜모노메틸에테르 등을; As the alcohol, for example, methyl alcohol, ethyl alcohol, isopropyl alcohol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, triethylene glycol, ethylene glycol monomethyl ether and the like;

상기 케톤으로서, 예를 들면 아세톤, 메틸에틸케톤, 메틸이소부틸케톤, 사이클로헥사논 등을; As the ketone, for example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone and the like;

상기 에스테르로서, 예를 들면 락트산 에틸, 락트산 부틸, 아세트산 메틸, 아세트산 에틸, 아세트산 부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 옥살산 디에틸, 말론산 디에틸 등을; As the ester, for example, ethyl lactate, butyl lactate, methyl acetate, ethyl acetate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, diethyl oxalate, diethyl malonate and the like;

상기 에테르로서, 예를 들면 디에틸에테르, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르, 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 테트라하이드로푸란 등을; Examples of the ether include diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, Ethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetraethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether acetate, Hydrofuran and the like;

상기 할로겐화 탄화 수소로서, 예를 들면 디클로로메탄, 1,2-디클로로에탄, 1,4-디클로로부탄, 트리클로로에탄, 클로로벤젠, o-디클로로벤젠 등을; As the halogenated hydrocarbon, for example, dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene and the like;

상기 탄화 수소로서, 예를 들면 헥산, 헵탄, 옥탄, 벤젠, 톨루엔, 자일렌, 이소아밀프로피오네이트, 이소아밀이소부틸레이트, 디이소펜틸에테르 등을 각각 들 수 있다. Examples of the hydrocarbons include hexane, heptane, octane, benzene, toluene, xylene, isoamyl propionate, isoamyl isobutylate, and diisopentyl ether.

이들 유기 용매 중, 비프로톤성 극성 용매 그리고 페놀 및 그 유도체로 이루어지는 군(제1군의 유기 용매)으로부터 선택되는 1종 이상, 또는 상기 제1군의 유기 용매로부터 선택되는 1종 이상과 알코올, 케톤, 에스테르, 에테르, 할로겐화 탄화 수소 및 탄화 수소로 이루어지는 군(제2군의 유기 용매)으로부터 선택되는 1종 이상과의 혼합물을 사용하는 것이 바람직하다. 후자의 경우, 제2군의 유기 용매의 사용 비율은, 제1군의 유기 용매 및 제2군의 유기 용매의 합계에 대하여, 바람직하게는 50중량% 이하이고, 보다 바람직하게는 40중량% 이하이고, 더욱이 30중량% 이하인 것이 바람직하다. Among these organic solvents, at least one selected from the group consisting of an aprotic polar solvent and a group consisting of phenol and a derivative thereof (first group of organic solvents), or at least one selected from organic solvents of the first group and an alcohol, It is preferable to use a mixture of at least one member selected from the group consisting of ketones, esters, ethers, halogenated hydrocarbons and hydrocarbons (organic solvent of the second group). In the latter case, the use ratio of the organic solvent of the second group is preferably 50% by weight or less, more preferably 40% by weight or less based on the total amount of the organic solvent of the first group and the organic solvent of the second group By weight, more preferably not more than 30% by weight.

유기 용매의 사용량(a)은, 테트라카본산 2무수물 및 디아민의 합계량(b)이, 반응 용액의 전체량(a+b)에 대하여 0.1∼50중량%가 되도록 하는 양으로 하는 것이 바람직하다. The amount (a) of the organic solvent used is preferably such that the total amount (b) of the tetracarboxylic acid dianhydride and the diamine is 0.1 to 50 wt% with respect to the total amount (a + b) of the reaction solution.

이상과 같이 하여, 폴리암산을 용해하여 이루어지는 반응 용액이 얻어진다.As described above, a reaction solution obtained by dissolving polyamic acid is obtained.

이 반응 용액은 그대로 액정 배향제의 조제에 제공해도 좋고, 반응 용액 중에 포함되는 폴리암산을 단리한 후에 액정 배향제의 조제에 제공해도 좋고, 또는 단리한 폴리암산을 정제한 후에 액정 배향제의 조제에 제공해도 좋다. 폴리암산을 탈수 폐환하여 폴리이미드로 하는 경우에는, 상기 반응 용액을 그대로 탈수 폐환 반응에 제공해도 좋고, 반응 용액 중에 포함되는 폴리암산을 단리한 후에 탈수 폐환 반응에 제공해도 좋고, 또는 단리한 폴리암산을 정제한 후에 탈수 폐환 반응에 제공해도 좋다. 폴리암산의 단리 및 정제는 공지의 방법에 따라 행할 수 있다. The reaction solution may be directly supplied to the preparation of the liquid crystal aligning agent. Alternatively, the polyamic acid contained in the reaction solution may be isolated and then supplied to the preparation of the liquid crystal aligning agent, or after the isolated polyamic acid is purified, . When the polyamic acid is subjected to dehydration ring closure to form a polyimide, the reaction solution may be directly supplied to the dehydration ring-closing reaction. Alternatively, the polyamic acid contained in the reaction solution may be isolated and then subjected to dehydration ring- May be purified and then subjected to a dehydration ring-closing reaction. The polyamic acid can be isolated and purified by a known method.

<폴리이미드의 합성> <Synthesis of polyimide>

상기 폴리이미드는, 상기와 같이 하여 합성된 폴리암산을 탈수 폐환하여 이미드화함으로써 얻을 수 있다. The polyimide can be obtained by dehydrating and ring closure of the polyamic acid synthesized as described above to imidize it.

본 발명에 있어서의 폴리이미드는, 그 전구체인 폴리암산이 갖고 있던 암산 구조 모두를 탈수 폐환한 완전 이미드화물이라도 좋고, 암산 구조의 일부만을 탈수 폐환하여, 암산 구조와 이미드환 구조가 병존하는 부분 이미드화물이라도 좋다. 본 발명에 있어서의 폴리이미드는, 그 이미드화율이 30% 이상인 것이 바람직하고, 50% 이상인 것이 보다 바람직하고, 특히 55% 이상인 것이 바람직하다. 이 이미드화율은, 폴리이미드의 암산 구조의 수와 이미드환 구조의 수와의 합계에 대한 이미드환 구조의 수가 차지하는 비율을 백분율로 나타낸 것이다. 여기에서, 이미드환의 일부가 이소이미드환이라도 좋다. The polyimide in the present invention may be a completely imidized product in which all of the arboric acid structure of the polyamic acid as a precursor thereof is subjected to dehydration ring closure and only a part of the arboric acid structure is subjected to dehydration ring closure, It may be an imaged cargo. The imide ratio of the polyimide in the present invention is preferably 30% or more, more preferably 50% or more, particularly preferably 55% or more. The imidization rate is a percentage of the ratio of the number of imide ring structures to the sum of the number of amide structure and the number of imide ring structure of polyimide. Here, a part of the imide ring may be an isoimide ring.

폴리암산의 탈수 폐환은, 바람직하게는 폴리암산을 가열하는 방법에 의해, 또는 폴리암산을 유기 용매에 용해하고, 이 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하여 필요에 따라서 가열하는 방법에 의해 행해진다. 이 중, 후자의 방법에 의한 것이 바람직하다. The dehydration ring-closure of the polyamic acid is preferably carried out by a method of heating the polyamic acid, or a method of dissolving the polyamic acid in an organic solvent, adding a dehydrating agent and a dehydrating ring-closing catalyst to the solution, and optionally heating . Of these, the latter method is preferable.

상기 폴리암산의 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하는 방법에 있어서, 탈수제로서는, 예를 들면 무수 아세트산, 무수 프로피온산, 무수 트리플루오로아세트산 등의 산 무수물을 이용할 수 있다. 탈수제의 사용량은, 폴리암산의 암산 구조 1몰에 대하여 0.01∼20몰로 하는 것이 바람직하다. 탈수 폐환 촉매로서는, 예를 들면 피리딘, 콜리딘, 루티딘, 트리에틸아민 등의 3급 아민을 이용할 수 있다. 탈수 폐환 촉매의 사용량은, 사용하는 탈수제 1몰에 대하여 0.01∼10몰로 하는 것이 바람직하다. 탈수 폐환 반응에 이용되는 유기 용매로서는, 폴리암산의 합성에 이용되는 것으로서 예시한 유기 용매를 들 수 있다. 탈수 폐환 반응의 반응 온도는 바람직하게는 0∼180℃이고, 보다 바람직하게는 10∼150℃이다. 반응 시간은 바람직하게는 1.0∼120시간이고, 보다 바람직하게는 2.0∼30시간이다. In the method of adding the dehydrating agent and the dehydrating ring-closing catalyst to the solution of the polyamic acid, an acid anhydride such as acetic anhydride, propionic anhydride, or trifluoroacetic anhydride can be used as the dehydrating agent. The amount of the dehydrating agent to be used is preferably 0.01 to 20 mol based on 1 mol of the acid structure of the polyamic acid. As the dehydration ring-closing catalyst, for example, tertiary amines such as pyridine, collidine, lutidine and triethylamine can be used. The amount of the dehydration ring-closing catalyst to be used is preferably 0.01 to 10 mol based on 1 mol of the dehydrating agent to be used. Examples of the organic solvent used in the dehydration ring-closure reaction include the organic solvents exemplified for use in the synthesis of polyamic acid. The reaction temperature of the dehydration ring-closing reaction is preferably 0 to 180 캜, more preferably 10 to 150 캜. The reaction time is preferably 1.0 to 120 hours, more preferably 2.0 to 30 hours.

이와 같이 하여 폴리이미드를 함유하는 반응 용액이 얻어진다. 이 반응 용액은, 이것을 그대로 액정 배향제의 조제에 제공해도 좋고, 반응 용액으로부터 탈수제 및 탈수 폐환 촉매를 제거한 후에 액정 배향제의 조제에 제공해도 좋고, 폴리이미드를 단리한 후에 액정 배향제의 조제에 제공해도 좋고, 또는 단리한 폴리이미드를 정제한 후에 액정 배향제의 조제에 제공해도 좋다. 이들 정제 조작은 공지의 방법에 따라 행할 수 있다. In this way, a reaction solution containing polyimide is obtained. This reaction solution may be provided as it is in the preparation of a liquid crystal aligning agent or may be provided in the preparation of a liquid crystal aligning agent after removing the dehydrating agent and the dehydration ring-closing catalyst from the reaction solution. Alternatively, after the polyimide is isolated, Or may be provided to the preparation of a liquid crystal aligning agent after purification of the isolated polyimide. These purification operations can be carried out according to a known method.

<중합체의 용액 점도> &Lt; Solution viscosity of polymer >

이상과 같이 하여 얻어지는 특정 중합체는, 이것을 농도 10중량%의 용액으로 했을 때에, 20∼800mPa·s의 용액 점도를 갖는 것이 바람직하고, 30∼500mPa·s의 용액 점도를 갖는 것이 보다 바람직하다. The specific polymer thus obtained preferably has a solution viscosity of 20 to 800 mPa · s and more preferably a solution viscosity of 30 to 500 mPa · s when the solution is a solution having a concentration of 10% by weight.

상기 중합체의 용액 점도(mPa·s)는, 당해 중합체의 양(良)용매(예를 들면 γ-부티로락톤, N-메틸-2-피롤리돈 등)를 이용하여 조제한 농도 10중량%의 중합체 용액에 대해서, E형 회전 점도계를 이용하여 25℃에서 측정한 값이다. The solution viscosity (mPa 占 퐏) of the polymer is preferably 10% by weight or less, more preferably 10% by weight or less, by using a good solvent (e.g.,? -Butyrolactone, N-methyl- Polymer solution was measured at 25 占 폚 using an E-type rotational viscometer.

<그 외의 첨가제> <Other additives>

본 발명의 액정 배향막은, 상기와 같은 특정 중합체를 필수 성분으로서 함유하지만, 필요에 따라서 그 외의 성분을 함유하고 있어도 좋다. 이러한 그 외의 성분으로서는, 예를 들면 상기 특정 중합체 이외의 중합체(이하, 「기타 중합체」라고 함), 분자 내에 적어도 1개의 에폭시기를 갖는 화합물(이하, 「에폭시 화합물」이라고 함), 관능성 실란 화합물 등을 들 수 있다. The liquid crystal alignment film of the present invention contains the above specific polymer as an essential component, but may contain other components as required. Examples of such other components include a polymer other than the specific polymer (hereinafter referred to as "another polymer"), a compound having at least one epoxy group in the molecule (hereinafter referred to as "epoxy compound"), a functional silane compound And the like.

[기타 중합체][Other Polymers]

상기 기타 중합체는, 용액 특성 및 전기 특성의 개선을 위해 사용할 수 있다. 이러한 기타 중합체는, 특정 중합체 이외의 중합체이며, 예를 들면 테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산으로서, 전체 테트라카본산 2무수물에 대한 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종의 함유 비율이 5몰% 미만이거나, 혹은 80몰%를 초과하는, 상기 폴리암산(이하, 「기타 폴리암산」이라고 함), 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드(이하,「기타 폴리이미드」라고 함), 폴리암산 에스테르, 폴리에스테르, 폴리아미드, 폴리실록산, 셀룰로오스 유도체, 폴리아세탈, 폴리스티렌 유도체, 폴리(스티렌-페닐말레이미드) 유도체, 폴리(메타)아크릴레이트 등을 들 수 있다. 이들 중, 기타 폴리암산 또는 기타 폴리이미드가 바람직하고, 기타 폴리암산이 보다 바람직하다. These other polymers can be used for improving solution properties and electrical properties. Such other polymer is a polymer other than the specific polymer, for example, a polyamic acid obtained by reacting a tetracarboxylic acid dianhydride with a diamine, wherein 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic acid Wherein the content ratio of at least one member selected from the group consisting of acid anhydrides and 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydrides is less than 5 mol% or more than 80 mol% (Hereinafter referred to as &quot; other polyamic acid &quot;), polyimide obtained by subjecting the polyamic acid to dehydration cyclization (hereinafter referred to as &quot; other polyimide &quot;), polyamic acid ester, polyester, polyamide, polysiloxane, , Polystyrene derivatives, poly (styrene-phenylmaleimide) derivatives, and poly (meth) acrylates. Of these, other polyamic acids or other polyimides are preferable, and other polyamic acids are more preferable.

상기 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 테트라카본산 2무수물로서는, 특정 중합체를 합성하기 위해 바람직하게 사용되는 그 외의 테트라카본산 2무수물로서 전술한 것과 동일한 것을 들 수 있지만, 바람직하게는 1,2,3,4-사이클로부탄테트라카본산 2무수물, 피로멜리트산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 및 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온으로 이루어지는 군으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. The tetracarboxylic acid dianhydride used for synthesizing the above other polyamic acid or other polyimide may be the same as the above-mentioned other tetracarboxylic dianhydrides preferably used for synthesizing a specific polymer, Cyclobutanetetracarboxylic acid dianhydride, pyromellitic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride and 1,3,3a, 4,5,9b-hexa (Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione desirable.

상기 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 디아민으로서는, 특정 중합체를 합성할 때에 이용되는 디아민으로서 상기에 예시한 것 중으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. 기타 폴리암산 또는 기타 폴리이미드를 합성하기 위해 이용되는 디아민으로서는, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 콜레스타닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 및 1,4-비스-(4-아미노페닐)-피페라진으로 이루어지는 군으로부터 선택되는 적어도 1종을 사용하는 것이 바람직하다. As the diamine to be used for synthesizing the above other polyamic acid or other polyimide, it is preferable to use at least one selected from among those exemplified above as a diamine to be used in synthesizing a specific polymer. Examples of diamines used for synthesizing other polyamic acids or other polyimides include 4,4'-diaminodiphenylmethane, 2,2'-dimethyl-4,4'-diaminobiphenyl, cholestanyloxy-2 , 4-diaminobenzene, 3,5-diaminobenzoic acid and 1,4-bis- (4-aminophenyl) -piperazine are preferably used.

기타 중합체의 사용 비율로서는, 중합체의 합계(상기의 특정 중합체 및 기타 중합체의 합계를 말함, 이하 동일)에 대하여 바람직하게는 50중량% 이하이고, 보다 바람직하게는 40중량% 이하이고, 더욱이 30중량% 이하인 것이 바람직하다. 기타 중합체를 사용하는 경우, 그 사용 비율을 중합체의 합계에 대하여 0.1중량% 이상으로 하면, 그 첨가의 효과가 의미 있게 발현된다. The proportion of the other polymer to be used is preferably 50% by weight or less, more preferably 40% by weight or less, further preferably 30% by weight or less based on the total amount of the polymers (referred to the total amount of the specific polymer and the other polymers described above, % Or less. When other polymers are used, if the use ratio is 0.1% by weight or more based on the total amount of the polymers, the effect of the addition is significantly expressed.

[에폭시 화합물] [Epoxy Compound]

에폭시 화합물은, 얻어지는 액정 배향막의 기판에 대한 접착성 및 내열성 등을 더욱 향상하는 목적에서, 본 발명의 액정 배향제에 함유될 수 있다. The epoxy compound may be contained in the liquid crystal aligning agent of the present invention for the purpose of further improving the adhesiveness and heat resistance of the obtained liquid crystal alignment film to the substrate.

상기 에폭시 화합물로서는, 분자 내에 2개 이상의 에폭시기를 갖는 에폭시 화합물이 바람직하며, 예를 들면 에틸렌글리콜디글리시딜에테르, 폴리에틸렌글리콜디글리시딜에테르, 프로필렌글리콜디글리시딜에테르, 트리프로필렌글리콜디글리시딜에테르, 폴리프로필렌글리콜디글리시딜에테르, 네오펜틸글리콜디글리시딜에테르, 1,6-헥산디올디글리시딜에테르, 글리세린디글리시딜에테르, 트리메틸올프로판트리글리시딜에테르, 2,2-디브로모네오펜틸글리콜디글리시딜에테르, N,N,N',N'-테트라글리시딜-m-자일렌디아민, 1,3-비스(N,N-디글리시딜아미노메틸)사이클로헥산, N,N,N',N'-테트라글리시딜-4,4'-디아미노디페닐메탄, N,N-디글리시딜-벤질아민, N,N-디글리시딜-아미노메틸사이클로헥산, N,N-디글리시딜-사이클로헥실아민 등을 바람직한 것으로서 들 수 있다. The epoxy compound is preferably an epoxy compound having two or more epoxy groups in the molecule, and examples thereof include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol di Glycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, trimethylol propane triglycidyl ether, 2,2-dibromonopentyl glycol diglycidyl ether, N, N, N ', N'-tetraglycidyl-m-xylylenediamine, 1,3-bis N, N ', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, N, N-diglycidyl-benzylamine, N, Glycidyl-aminomethylcyclohexane, N, N-diglycidyl-cyclohexylamine, and the like are preferably used .

에폭시 화합물은, 그 사용 비율이 과소하면 상기와 같은 소기의 효과가 충분히 발현되지 않고, 한편 사용 비율이 과대하면 액정 배향막의 리워크성 및 러빙 내성이 손상된다. 이러한 관점에서 에폭시 화합물의 배합 비율은, 중합체의 합계 100중량부에 대하여, 30중량부 이하로 하는 것이 바람직하고, 0.1∼15중량부로 하는 것이 보다 바람직하고, 바람직하게는 0.5∼8중량부로 하는 것이 더욱 바람직하고, 특히 1∼3중량부로 하는 것이 바람직하다. When the use ratio is too low, the above-mentioned desired effects are not sufficiently exhibited. On the other hand, if the use ratio is excessive, the reworkability and rubbing resistance of the liquid crystal alignment film are impaired. From this point of view, the blending ratio of the epoxy compound is preferably 30 parts by weight or less, more preferably 0.1 to 15 parts by weight, and preferably 0.5 to 8 parts by weight, based on 100 parts by weight of the total amount of the polymer More preferably 1 to 3 parts by weight.

[관능성 실란 화합물] [Functional silane compound]

상기 관능성 실란 화합물로서는, 예를 들면 3-아미노프로필트리메톡시실란, 3-아미노프로필트리에톡시실란, 2-아미노프로필트리메톡시실란, 2-아미노프로필트리에톡시실란, N-(2-아미노에틸)-3-아미노프로필트리메톡시실란, N-(2-아미노에틸)-3-아미노프로필메틸디메톡시실란, 3-우레이도프로필트리메톡시실란, 3-우레이도프로필트리에톡시실란, N-에톡시카보닐-3-아미노프로필트리메톡시실란, N-에톡시카보닐-3-아미노프로필트리에톡시실란, N-트리에톡시실릴프로필트리에틸렌트리아민, N-트리메톡시실릴프로필트리에틸렌트리아민, 10-트리메톡시실릴-1,4,7-트리아자데칸, 10-트리에톡시실릴-1,4,7-트리아자데칸, 9-트리메톡시실릴-3,6-디아자노닐아세테이트, 9-트리에톡시실릴-3,6-디아자노닐아세테이트, 9-트리메톡시실릴-3,6-디아자노난산 메틸, 9-트리에톡시실릴-3,6-디아자노난산 메틸, N-벤질-3-아미노프로필트리메톡시실란, N-벤질-3-아미노프로필트리에톡시실란, N-페닐-3-아미노프로필트리메톡시실란, N-페닐-3-아미노프로필트리에톡시실란, 글리시독시메틸트리메톡시실란, 글리시독시메틸트리에톡시실란, 2-글리시독시에틸트리메톡시실란, 2-글리시독시에틸트리에톡시실란, 3-글리시독시프로필트리메톡시실란, 3-글리시독시프로필트리에톡시실란 등을 들 수 있다. Examples of the functional silane compound include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N- (2 -Aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxy Silane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N- Trimethoxysilyl-1,4,7-triazadecane, 10-triethoxysilyl-1,4,7-triazadecane, 9-trimethoxysilyl-3 , 6-diazanonyl acetate, 9-triethoxysilyl-3,6-diazanonyl acetate, methyl 9-trimethoxysilyl-3,6-diazononanoate, Benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl- N-phenyl-3-aminopropyltriethoxysilane, glycidoxymethyltrimethoxysilane, glycidoxymethyltriethoxysilane, 2-glycidoxyethyltrimethoxysilane, 2-glycidoxyethyltriethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropyltriethoxysilane, and the like.

이들 관능성 실란 화합물의 배합 비율은, 중합체의 합계 100중량부에 대하여, 바람직하게는 2중량부 이하, 보다 바람직하게는 0.02∼0.2중량부이다. The blending ratio of these functional silane compounds is preferably 2 parts by weight or less, more preferably 0.02 to 0.2 parts by weight, based on 100 parts by weight of the total of the polymers.

<액정 배향제><Liquid Crystal Aligner>

본 발명의 액정 배향제는, 상기와 같은 특정 중합체 및 필요에 따라서 임의적으로 배합되는 그 외의 첨가제가, 바람직하게는 유기 용매 중에 용해 함유되어 구성된다. The liquid crystal aligning agent of the present invention is constituted by dissolving and incorporating the above-mentioned specific polymer and optionally other additives optionally added in an organic solvent.

본 발명의 액정 배향제에 사용되는 유기 용매로서는, 예를 들면 N-메틸-2-피롤리돈, γ-부티로락톤, γ-부티로락탐, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 4-하이드록시-4-메틸-2-펜타논, 에틸렌글리콜모노메틸에테르, 락트산 부틸, 아세트산 부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르(부틸셀로솔브), 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 디이소부틸케톤, 이소아밀프로피오네이트, 이소아밀이소부틸레이트, 디이소펜틸에테르, 에틸렌카보네이트, 프로필렌카보네이트 등을 들 수 있다. 이들은 단독으로 사용할 수 있고, 또는 2종 이상을 혼합하여 사용할 수 있다. Examples of the organic solvent used in the liquid crystal aligning agent of the present invention include N-methyl-2-pyrrolidone,? -Butyrolactone,? -Butyrolactam, N, N-dimethylformamide, Methylene-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene Diethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether (ethylene glycol diethyl ether), ethylene glycol n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol- , Diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, di Isobutyl ketone, isoamyl propionate, isoamyl isobutyrate, di-isopentyl ether, ethylene carbonate, propylene carbonate, and the like. These may be used alone or in combination of two or more.

본 발명의 액정 배향제에 있어서의 고형분 농도(액정 배향제의 용매 이외의 성분의 합계 중량이 액정 배향제의 전체 중량에서 차지하는 비율)는, 점성, 휘발성 등을 고려하여 적절히 선택되지만, 바람직하게는 1∼10중량%의 범위이다. 즉, 본 발명의 액정 배향제는, 후술하는 바와 같이 기판 표면에 도포되어, 바람직하게는 가열됨으로써 액정 배향막인 도막 또는 액정 배향막이 되는 도막이 형성되지만, 고형분 농도가 1중량% 미만인 경우에는, 이 도막의 막두께가 과소하게 되어 양호한 액정 배향막을 얻을 수 없고, 한편 고형분 농도가 10중량%를 초과하는 경우에는, 도막의 막두께가 과대하게 되어 양호한 액정 배향막을 얻을 수 없고, 또한, 액정 배향제의 점성이 증대하여 도포 특성이 떨어지는 것이 된다. The solid concentration of the liquid crystal aligning agent of the present invention (the ratio of the total weight of components other than the solvent of the liquid crystal aligning agent to the total weight of the liquid crystal aligning agent) is appropriately selected in consideration of viscosity, volatility, etc., 1 to 10% by weight. That is, the liquid crystal aligning agent of the present invention is applied to the surface of the substrate as described later, and is preferably heated to form a coating film which becomes a liquid crystal alignment film or a liquid crystal alignment film. When the solid concentration is less than 1 wt% If the concentration of the solid content exceeds 10% by weight, the film thickness of the coating film becomes excessively large, so that a good liquid crystal alignment film can not be obtained. In addition, the liquid crystal alignment film The viscosity is increased and the coating properties are deteriorated.

특히 바람직한 고형분 농도의 범위는, 기판에 액정 배향제를 도포할 때에 이용하는 방법에 따라 상이하다. 예를 들면 스피너법에 의한 경우에는 고형분 농도 1.5∼4.5중량%의 범위가 특히 바람직하다. 인쇄법에 의한 경우에는, 고형분 농도를 3∼9중량%의 범위로 하고, 그에 따라 용액 점도를 12∼50mPa·s의 범위로 하는 것이 특히 바람직하다. 잉크젯법에 의한 경우에는, 고형분 농도를 1∼5중량%의 범위로 하고, 그에 따라, 용액 점도를 3∼15mPa·s의 범위로 하는 것이 특히 바람직하다. A particularly preferable range of the solid concentration is different depending on the method used when the liquid crystal aligning agent is applied to the substrate. For example, in the case of the spinner method, the solid content concentration is particularly preferably in the range of 1.5 to 4.5% by weight. In the case of the printing method, it is particularly preferable to set the solid concentration in the range of 3 to 9% by weight and the solution viscosity in the range of 12 to 50 mPa · s accordingly. In the case of the ink-jet method, it is particularly preferable that the solid concentration is in the range of 1 to 5 wt%, and thus the solution viscosity is in the range of 3 to 15 mPa · s.

본 발명의 액정 배향제를 조제할 때의 온도는, 바람직하게는 10∼50℃이고, 보다 바람직하게는 20∼30℃이다. The temperature for preparing the liquid crystal aligning agent of the present invention is preferably 10 to 50 占 폚, more preferably 20 to 30 占 폚.

<액정 표시 소자> <Liquid crystal display element>

본 발명의 액정 표시 소자는, 상기와 같은 본 발명의 액정 배향제로 형성된 액정 배향막을 구비하는 것이다. 보다 상세하게는, 본 발명의 액정 표시 소자는, 액정 셀의 양(兩) 외면에 편광판을 배치하여 이루어지는 것으로서, 당해 액정 셀은, 액정 배향막을 갖는 기판의 2매를 각 액정 배향막면이 상대하도록 대향 배치한 간극에 액정층을 협지한 구성을 갖고, 그리고 상기 액정 배향막이 본 발명의 액정 배향제로 형성된 것인 것을 특징으로 한다. The liquid crystal display element of the present invention comprises the liquid crystal alignment layer formed of the liquid crystal aligning agent of the present invention as described above. More specifically, the liquid crystal display element of the present invention is formed by disposing a polarizing plate on both outer surfaces of a liquid crystal cell. In the liquid crystal cell, two liquid crystal alignment films are aligned so that two liquid crystal alignment film surfaces face each other And the liquid crystal alignment layer is formed of the liquid crystal aligning agent of the present invention.

이러한 본 발명의 액정 표시 소자는, 예를 들면 이하 (1) 내지 (3)의 공정에 의해 제조할 수 있다. 공정 (1)은, 소망하는 동작 모드에 따라 사용 기판이 상이하다. 공정 (2) 및 (3)은 각 동작 모드에 공통이다. Such a liquid crystal display element of the present invention can be produced, for example, by the following steps (1) to (3). In the step (1), the substrate to be used differs depending on a desired operation mode. Steps (2) and (3) are common to each operation mode.

(1) 우선 기판 상에 본 발명의 액정 배향제를 도포하고, 이어서 도포면을 가열함으로써 기판 상에 도막을 형성한다. (1) First, a liquid crystal aligning agent of the present invention is applied onto a substrate, and then a coated film is formed on the substrate by heating the coated surface.

(1-1) TN형, STN형 또는 VA형 액정 표시 소자를 제조하는 경우, 패터닝된 투명 도전막이 편면에 형성되어 있는 기판 2매를 한 쌍으로 하고, 그 각 투명 도전막 형성면 상에, 본 발명의 액정 배향제를, 바람직하게는 오프셋 인쇄법, 스핀 코팅법 또는 잉크젯 인쇄법에 의해 각각 도포하고, 이어서, 각 도포면을 가열함으로써 도막을 형성한다. 여기에, 기판으로서는, 예를 들면 플로트 유리, 소다 유리 등의 유리; 폴리에틸렌테레프탈레이트, 폴리부틸렌테레프탈레이트, 폴리에테르술폰, 폴리카보네이트, 폴리(지환식 올레핀) 등의 플라스틱으로 이루어지는 투명 기판을 이용할 수 있다. 기판의 편면에 형성되는 투명 도전막으로서는, 산화 주석(SnO2)으로 이루어지는 NESA막(미국 PPG사 등록 상표), 산화 인듐-산화 주석(In2O3-SnO2)으로 이루어지는 ITO막 등을 이용할 수 있고, 패터닝된 투명 도전막을 얻으려면, 예를 들면 패턴 없는 투명 도전막을 형성한 후 포토·에칭에 의해 패턴을 형성하는 방법, 투명 도전막을 형성할 때에 소망하는 패턴을 갖는 마스크를 이용하는 방법 등에 의할 수 있다. 액정 배향제의 도포시에는, 기판 표면 및 투명 도전막과 도막과의 접착성을 더욱 양호하게 하기 위해, 기판 표면 중 도막을 형성해야 하는 면에, 관능성 실란 화합물, 관능성 티탄 화합물 등을 미리 도포하는 전(前)처리를 시행해 두어도 좋다. (1-1) In the case of producing a TN type, STN type or VA type liquid crystal display device, two pairs of substrates each having a patterned transparent conductive film formed on one side thereof are formed as a pair, The liquid crystal aligning agent of the present invention is preferably applied by an offset printing method, a spin coating method, or an inkjet printing method, respectively, and then each coated surface is heated to form a coated film. Examples of the substrate include glass such as float glass and soda glass; A transparent substrate made of plastic such as polyethylene terephthalate, polybutylene terephthalate, polyether sulfone, polycarbonate, and poly (alicyclic olefin) can be used. As the transparent conductive film to be formed on one surface of the substrate, an ITO film made of NESA film (a registered trademark of PPG Corporation of the US) or indium oxide-tin oxide (In 2 O 3 -SnO 2 ) made of tin oxide (SnO 2 ) In order to obtain a patterned transparent conductive film, for example, a method of forming a pattern by photoetching after forming a patternless transparent conductive film, a method of using a mask having a desired pattern in forming a transparent conductive film, and the like can do. When the liquid crystal aligning agent is applied, a functional silane compound, a functional titanium compound or the like may be added to the surface of the substrate surface on which the coating film should be formed, in order to improve the adhesion between the substrate surface and the transparent conductive film and the coating film It is also possible to carry out the pre-treatment for applying the coating.

액정 배향제 도포 후, 도포한 배향제의 액흐름 방지 등의 목적에서, 바람직하게는 예비 가열(프리베이킹)이 시행된다. 프리베이킹 온도는 바람직하게는 30∼200℃이고, 보다 바람직하게는 40∼150℃이고, 특히 바람직하게는 40∼100℃이다. 프리베이킹 시간은 바람직하게는 0.25∼10분이고, 보다 바람직하게는 0.5∼5분이다. 그 후, 용매를 완전히 제거하고, 필요에 따라서 폴리암산을 열이미드화하는 것을 목적으로 하여 소성(포스트베이킹) 공정이 실시된다. 이 소성(포스트베이킹) 온도는 바람직하게는 80∼300℃이고, 보다 바람직하게는 120∼250℃이다. 포스트베이킹 시간은 바람직하게는 5∼200분이고, 보다 바람직하게는 10∼100분이다. 이와 같이 하여, 형성되는 막의 막두께는, 바람직하게는 0.001∼1㎛이고, 보다 바람직하게는 0.005∼0.5㎛이다. Pre-heating (pre-baking) is preferably performed for the purpose of preventing the liquid flow of the applied aligning agent after application of the liquid crystal aligning agent. The prebaking temperature is preferably 30 to 200 캜, more preferably 40 to 150 캜, particularly preferably 40 to 100 캜. The prebaking time is preferably 0.25 to 10 minutes, more preferably 0.5 to 5 minutes. Thereafter, the baking (post-baking) step is carried out for the purpose of completely removing the solvent and, if necessary, thermally modifying the polyamic acid. The firing (post-baking) temperature is preferably 80 to 300 占 폚, and more preferably 120 to 250 占 폚. The post baking time is preferably 5 to 200 minutes, more preferably 10 to 100 minutes. The film thickness of the film thus formed is preferably 0.001 to 1 占 퐉, and more preferably 0.005 to 0.5 占 퐉.

(1-2) 한편, 횡전계 방식의 액정 표시 소자를 제조하는 경우, 빗살형으로 패터닝된 투명 도전막이 편면에 형성되어 있는 기판의 도전막 형성면과, 도전막이 형성되어 있지 않은 대향 기판의 편면에, 본 발명의 액정 배향제를 각각 도포하고, 이어서 각 도포면을 가열함으로써 도막을 형성한다. (1-2) On the other hand, when a transverse electric field type liquid crystal display element is manufactured, the conductive film formation surface of the substrate on which the transparent conductive film patterned in the comb shape is formed on one side, , The liquid crystal aligning agent of the present invention is respectively applied, and then each coated surface is heated to form a coated film.

이때 사용되는 기판 및 투명 도전막의 재질, 투명 도전막의 패터닝 방법, 기판의 전처리, 액정 배향제의 도포 방법, 액정 배향제를 도포한 후의 가열 방법 그리고 형성되는 도막의 막두께에 대해서는 상기 (1-1)과 동일하다. The substrate and the transparent conductive film to be used at this time, the method of patterning the transparent conductive film, the pretreatment of the substrate, the application method of the liquid crystal aligning agent, the heating method after application of the liquid crystal aligning agent, ).

(2) 본 발명의 방법에 의해 제조되는 액정 표시 소자가 VA형의 액정 표시 소자인 경우에는, 상기와 같이 하여 형성된 도막을 그대로 액정 배향막으로서 사용할 수 있지만, 소망하는 바에 따라서 다음에 서술하는 러빙 처리를 행한 후에 사용에 제공해도 좋다. (2) When the liquid crystal display element produced by the method of the present invention is a VA type liquid crystal display element, the coating film formed as described above can be used as it is as a liquid crystal alignment film as it is. However, And may be provided for use.

한편, VA형 이외의 액정 표시 소자를 제조하는 경우에는, 상기와 같이 하여 형성된 도막에 러빙 처리를 시행함으로써 액정 배향막으로 한다. On the other hand, in the case of manufacturing a liquid crystal display device other than VA type, a coating film formed as described above is subjected to rubbing treatment to form a liquid crystal alignment film.

러빙 처리는, 상기와 같이 하여 형성된 도막면에 대하여, 예를 들면 나일론, 레이온, 코튼 등의 섬유로 이루어지는 천을 감은 롤로 일정 방향으로 문지름으로써 행할 수 있다. 이에 따라, 액정 분자의 배향능이 도막에 부여되어 액정 배향막이 된다. The rubbing treatment can be performed by rubbing the coating film surface formed as described above in a predetermined direction with a roll formed of a fiber such as nylon, rayon, or cotton, for example. Accordingly, the alignment ability of the liquid crystal molecules is imparted to the coating film to form a liquid crystal alignment film.

또한, 상기와 같이 하여 형성된 액정 배향막에 대하여, 예를 들면 액정 배향막의 일부에 자외선을 조사함으로써 액정 배향막의 일부 영역의 프리틸트각을 변화시키는 처리(특허문헌 11(일본공개특허공보 평6-222366호)및 특허문헌 12(일본공개특허공보 평6-281937호) 참조), 액정 배향막 표면의 일부에 레지스트막을 형성한 후에 앞선 러빙 처리와 상이한 방향으로 러빙 처리를 행한 후에 레지스트막을 제거하는 처리를 행하여, 액정 배향막이 영역마다 상이한 액정 배향능을 갖도록 함으로써 얻어지는 액정 표시 소자의 시계(視界) 특성을 개선하는 것(특허문헌 13(일본공개특허공보 평5-107544호) 참조) 등이 가능하다. Further, with respect to the liquid crystal alignment film formed as described above, for example, a treatment for changing a pretilt angle of a part of the liquid crystal alignment film by irradiating a part of the liquid crystal alignment film with ultraviolet rays (Patent Document 11 (Japanese Patent Application Laid- Japanese Patent Application Laid-open No. Hei 6-281937), a process of forming a resist film on a part of the surface of the liquid crystal alignment film and rubbing the film in a direction different from the rubbing process before the process of removing the resist film is performed (See Patent Document 13 (Japanese Patent Application Laid-Open No. 5-107544)), and the like, which improves the visual field characteristics of a liquid crystal display element obtained by causing the liquid crystal alignment film to have a liquid crystal aligning ability different for each region.

(3) 상기와 같이 하여 액정 배향막이 형성된 기판을 2매 준비하고, 대향 배치한 2매의 기판 간에 액정을 배치함으로써, 액정 셀을 제조한다. 여기에서, 도막에 대하여 러빙 처리를 행한 경우에는, 2매의 기판은, 각 도막에 있어서의 러빙 방향이 서로 소정의 각도, 예를 들면 직교 또는 역평행이 되도록 대향 배치된다. (3) A liquid crystal cell is prepared by preparing two substrates on which the liquid crystal alignment film is formed as described above, and arranging the liquid crystal between two substrates opposed to each other. Here, when the coating film is subjected to the rubbing treatment, the two substrates are opposed to each other such that the rubbing directions of the coating films are at a predetermined angle, for example, orthogonal or anti-parallel to each other.

액정 셀을 제조하려면, 예를 들면 이하의 2가지 방법을 들 수 있다. For example, the following two methods can be used to manufacture the liquid crystal cell.

제1 방법은, 종래부터 알려져 있는 방법이다. 우선, 각각의 액정 배향막이 대향되도록 간극(셀 갭)을 통하여 2매의 기판을 대향 배치하고, 2매의 기판의 주변부를 시일제를 이용하여 접합하고, 기판 표면 및 시일제에 의해 구획된 셀 갭 내에 액정을 주입 충전한 후, 주입공을 봉지함으로써, 액정 셀을 제조할 수 있다. The first method is a conventionally known method. First, two substrates are opposed to each other through a gap (cell gap) so that the respective liquid crystal alignment films are opposed to each other. The peripheral portions of the two substrates are bonded to each other using a sealant, The liquid crystal is injected and filled in the gap, and then the injection hole is sealed, whereby the liquid crystal cell can be manufactured.

제2 방법은, ODF(One Drop Fill) 방식이라고 불리는 수법이다. 액정 배향막을 형성한 2매의 기판 중 한쪽의 기판 상의 소정의 장소에 예를 들면 자외광 경화성의 시일제를 도포하고, 추가로 액정 배향막면 상의 소정에 수 개소에 액정을 적하한 후, 액정 배향막이 대향되도록 다른 한쪽의 기판을 접합함과 함께 액정을 기판의 전체면에 펴 바르고, 이어서 기판의 전체면에 자외광을 조사하여 시일제를 경화함으로써, 액정 셀을 제조할 수 있다. The second method is a so-called ODF (One Drop Fill) method. For example, an ultraviolet curable sealant is applied to a predetermined position on one of the two substrates on which the liquid crystal alignment film is formed, and further liquid crystal is dropped to a predetermined position on a predetermined position on the liquid crystal alignment film surface, The liquid crystal cell can be manufactured by spreading the liquid crystal on the entire surface of the substrate and then irradiating the entire surface of the substrate with ultraviolet light to cure the sealant.

어느 방법에 의한 경우라도, 상기와 같이 하여 제조한 액정 셀에 대해서, 이어서, 이용한 액정이 등방상(等方相)을 취하는 온도까지 가열한 후, 실온까지 서서히 냉각함으로써, 액정 주입시의 유동 배향을 제거하는 것이 바람직하다. Regardless of the method, the liquid crystal cell manufactured as described above is then heated to a temperature at which the liquid crystal used has an isotropic phase, and then slowly cooled to room temperature to obtain a liquid crystal cell having a flow orientation Is preferably removed.

그리고, 액정 셀의 외측 표면에 편광판을 접합함으로써, 본 발명의 액정 표시 소자를 얻을 수 있다. The liquid crystal display element of the present invention can be obtained by bonding a polarizing plate to the outer surface of the liquid crystal cell.

여기에서, 시일제로서는, 예를 들면 경화제 및 스페이서로서의 산화 알루미늄구(球)를 함유하는 에폭시 수지 등을 이용할 수 있다. As the sealing agent, for example, an epoxy resin containing an aluminum oxide sphere as a curing agent and a spacer can be used.

상기 액정으로서는, 예를 들면 네마틱형 액정, 스멕틱형 액정 등을 이용할 수 있고, 이들 중 네마틱형 액정이 바람직하며, 예를 들면 시프베이스계 액정, 아족시계 액정, 비페닐계 액정, 페닐사이클로헥산계 액정, 에스테르계 액정, 테르페닐계 액정, 비페닐사이클로헥산계 액정, 피리미딘계 액정, 디옥산계 액정, 바이사이클로옥탄계 액정, 쿠반계 액정 등을 이용할 수 있다. 또한, 이들 액정에, 예를 들면 콜레스테릴클로라이드, 콜레스테릴노나에이트, 콜레스테릴카보네이트 등의 콜레스테릭 액정; 상품명 C-15, CB-15(메르크사 제조)로서 판매되고 있는 것과 같은 키랄제; p-데실옥시벤질리덴-p-아미노-2-메틸부틸신나메이트 등의 강(强)유전성 액정 등을 추가로 첨가하여 사용해도 좋다. As the liquid crystal, for example, a nematic liquid crystal, a smectic liquid crystal and the like can be used. Among them, a nematic liquid crystal is preferable, and for example, a cypher base liquid crystal, an agar liquid crystal, a biphenyl liquid crystal, a phenylcyclohexane There can be used a liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenyl cyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a quartz liquid crystal and the like. Further, to these liquid crystals, for example, cholesteric liquid crystals such as cholesteryl chloride, cholesteryl nonanoate and cholesteryl carbonate; Chiral agents such as those sold under the trade names C-15 and CB-15 (Merck); p-decyloxybenzylidene-p-amino-2-methylbutyl cinnamate and the like may be further added and used.

액정 셀의 외표면에 접합되는 편광판으로서는, 폴리비닐알코올을 연신 배향시키면서 요오드를 흡수시킨 「H막」이라고 칭해지는 편광막을 아세트산 셀룰로오스 보호막 사이에 끼운 편광판 또는 H막 그 자체로 이루어지는 편광판을 들 수 있다. As the polarizing plate to be bonded to the outer surface of the liquid crystal cell, a polarizing plate in which a polarizing film called "H film" in which iodine is absorbed while polyvinyl alcohol is oriented in a stretched polyvinyl alcohol is sandwiched between cellulose acetate protective films or a polarizing plate comprising H film itself .

(실시예)(Example)

이하, 본 발명을 실시예에 의해 더욱 구체적으로 설명하지만, 본 발명은 이들 실시예에 제한되는 것은 아니다. 중합예에 있어서의 각 중합체 용액의 용액 점도 및 폴리이미드의 이미드화율은 이하의 방법에 의해 측정했다. Hereinafter, the present invention will be described more specifically by way of examples, but the present invention is not limited to these examples. The solution viscosity of each polymer solution in the polymerization example and the imidization rate of the polyimide were measured by the following methods.

[중합체 용액의 용액 점도] [Solution viscosity of polymer solution]

중합체 용액의 용액 점도(mPa·s)는, 각 합성예에 기재된 용매 및 농도에 있어서, E형 회전 점도계를 이용하여 25℃에서 측정했다. The solution viscosity (mPa 占 퐏) of the polymer solution was measured at 25 占 폚 using the E-type rotational viscometer at the solvent and the concentration described in each Synthesis Example.

[폴리이미드의 이미드화율] [Imidization Rate of Polyimide]

폴리이미드의 용액을 소량 분취하여 순수(純水)에 투입하고, 얻어진 침전을 실온에서 충분히 감압 건조한 후, 중수소화 디메틸술폭사이드에 용해하고, 테트라메틸실란을 기준 물질로 하여 실온에서 1H-NMR을 측정했다. 얻어진 1H-NMR 스펙트럼으로부터, 하기 수식 (1)로 나타나는 식에 의해 이미드화율을 구했다. A small amount of the polyimide solution was added to pure water and the resulting precipitate was sufficiently dried under reduced pressure at room temperature and then dissolved in deuterated dimethyl sulfoxide and subjected to 1 H-NMR at room temperature using tetramethylsilane as a reference . From the obtained 1 H-NMR spectrum, the imidization rate was determined by the equation shown by the following formula (1).

이미드화율(%)=(1-A1/A2×α)×100 (1) Imidization ratio (%) = (1-A 1 / A 2 × α) × 100 (1)

(수식 (1) 중, A1은 화학 시프트 10ppm 부근에 나타나는 NH기의 프로톤 유래의 피크 면적이고, (In the formula (1), A 1 is the peak area originating from the proton of the NH group near the chemical shift of 10 ppm,

A2는 그 외의 프로톤 유래의 피크 면적이고, A 2 is the peak area derived from other proton,

α는 중합체의 전구체(폴리암산)에 있어서의 NH기의 프로톤 1개에 대한 그 외의 프로톤의 개수 비율임) and? is the ratio of the number of other protons to one proton of the NH group in the polymer precursor (polyamic acid)

<TN형 액정 배향제용 중합체의 합성 및 안정성 평가> <Synthesis and Stability Evaluation of Polymer for TN Type Liquid Crystal Aligner>

[특정 중합체로서의 폴리암산의 합성예] [Example of synthesis of polyamic acid as a specific polymer]

합성예 A-TN1 Synthesis Example A-TN1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 피로멜리트산 2무수물 109g(0.50몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 246g 및 γ-부티로락톤 2,213g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-TN1)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 179mPa·s였다. (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 109 g (0.50 mol) of pyromellitic dianhydride as a tetracarboxylic acid dianhydride and 4,4'-diaminodiphenylmethane (A-TN1) was obtained by dissolving 198 g (1.0 mole) of the compound (A-TN1) in a mixed solvent consisting of 246 g of N-methyl-2-pyrrolidone and 2,213 g of? -Butyrolactone, Was obtained. The solution viscosity of this solution was 179 mPa s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 A-TN2 Synthesis Example A-TN2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 67g(0.30몰) 및 피로멜리트산 2무수물 153g(0.70몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 246g 및 γ-부티로락톤 2,213g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-TN2)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 153mPa·s였다. 67 g (0.30 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 153 g (0.70 mol) of pyromellitic dianhydride as tetracarboxylic dianhydrides and 4,4'-diaminodiphenylmethane (A-TN2) was obtained by dissolving 198g (1.0 mole) in a mixed solvent consisting of 246g of N-methyl-2-pyrrolidone and 2,213g of? -Butyrolactone, Was obtained. The solution viscosity of this solution was 153 mPa..

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-TN3 Synthesis Example a-TN3

테트라카본산 2무수물로서 피로멜리트산 2무수물 109g(0.50몰) 및 1,2,3,4-사이클로부탄테트라카본산 2무수물 98g(0.50몰) 그리고 디아민으로서 4,4'-디아미노디페닐메탄 198g(1.0몰)을, N-메틸-2-피롤리돈 230g 및 γ-부티로락톤 2,068g으로 이루어지는 혼합 용매에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-TN3)을 15중량% 함유하는 용액을 얻었다. 이 용액의 용액 점도는 193mPa·s였다. 109 g (0.50 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride, 98 g (0.50 mol) of 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride and 4,4'-diaminodiphenylmethane (A-TN3) was obtained by dissolving 198g (1.0 mole) in a mixed solvent consisting of 230 g of N-methyl-2-pyrrolidone and 2,068 g of? -Butyrolactone and conducting the reaction at 40 占 폚 for 3 hours, Was obtained. The solution viscosity of this solution was 193 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[특정 중합체로서의 폴리이미드의 합성예] [Example of synthesis of polyimide as specific polymer]

합성예 B-TN1 Synthesis Example B-TN1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 106g(0.985몰) 및 3-(3,5-디아미노벤조일옥시) 콜레스탄 7.8g(0.015몰)을 N-메틸-2-피롤리돈 3,042g에 용해하여, 60℃에서 6시간 반응을 행함으로써, 폴리암산을 함유하는 용액을 얻었다. 여기에서 얻어진 폴리암산 용액의 용액 점도는 160mPa·s였다. (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic acid dianhydride, and p- (0.0155 mol) of phenylenediamine and 7.8 g (0.015 mol) of 3- (3,5-diaminobenzoyloxy) cholestane were dissolved in 3,042 g of N-methyl-2-pyrrolidone, The reaction was carried out to obtain a solution containing polyamic acid. The solution viscosity of the obtained polyamic acid solution was 160 mPa · s.

얻어진 폴리암산 용액에, N-메틸-2-피롤리돈 3,380g을 추가하고, 피리딘 395g 및 무수 아세트산 306g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계(系) 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고(본 조작에서 이미드화 반응에 사용한 피리딘 및 무수 아세트산을 계 외로 제거함, 이하 동일), 추가로 농축함으로써, 이미드화율 약 94%의 폴리이미드(B-TN1)를 10중량% 함유하는 용액을 얻었다. To the resulting polyamic acid solution, 3,380 g of N-methyl-2-pyrrolidone was added, and 395 g of pyridine and 306 g of acetic anhydride were added, followed by dehydration ring-closure reaction at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a solvent with a new? -Butyrolactone (in this operation, pyridine and anhydrous acetic acid used in the imidization reaction were removed from the system, the same applies hereinafter) To obtain a solution containing 10% by weight of a polyimide (B-TN1) having a durability of about 94%.

이 용액을 소량 분취하여, γ-부티로락톤을 더하여 농도 6중량%의 용액으로 하여 측정한 용액 점도는 28mPa·s였다. A small amount of this solution was fractionated and? -Butyrolactone was added thereto to give a solution having a concentration of 6 wt%, and the solution viscosity was 28 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-TN2 Synthesis Example b-TN2

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 110g(0.50몰) 및 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)나프토[1,2-c]푸란-1,3-디온 155g(0.50몰), 디아민으로서 p-페닐렌디아민 92g(0.87몰), 비스아미노프로필테트라메틸디실록산 25g(0.10몰) 및 3,6-비스(4-아미노벤조일옥시)콜레스탄 13g(0.02몰) 그리고 모노아민으로서 아닐린 2.7g(0.030몰)을 N-메틸-2-피롤리돈 960g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산을 함유하는 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 59mPa·s였다. (0.50 mole) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as the tetracarboxylic acid dianhydride, and 110 g (0.50 mole) of 1,3,3a, 4,5,9b-hexahydro-8- 155 g (0.50 mol) of p-phenylenediamine as diamine, 92 g (0.87 mol) of bis-aminopropyl (0.10 mole) of tetramethyldisiloxane, 13 g (0.02 mole) of 3,6-bis (4-aminobenzoyloxy) cholestane and 2.7 g (0.030 mole) of aniline as a monoamine were dissolved in N-methyl- And the reaction was carried out at 60 DEG C for 6 hours to obtain a solution containing polyamic acid. A small amount of the resulting polyamic acid solution was collected and N-methyl-2-pyrrolidone was added thereto to prepare a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 59 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,700g을 추가하고, 피리딘 396g 및 무수 아세트산 409g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고, 추가로 농축함으로써, 이미드화율 약 95%의 폴리이미드(b-TN2)를 15중량% 함유하는 용액 약 2,520g을 얻었다. 이 폴리이미드 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 6.0중량%의 용액으로 하여 측정한 용액 점도는 18mPa·s였다. Then, 2,700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 396 g of pyridine and 409 g of acetic anhydride were added, followed by dehydration cyclization at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a solvent with fresh? -Butyrolactone and further concentrated to obtain about 2,520 g of a solution containing 15% by weight of polyimide (b-TN2) having an imidization rate of about 95% . A small amount of the polyimide solution was fractionated and? -Butyrolactone was added thereto to obtain a solution having a polyimide concentration of 6.0 wt%, and the solution viscosity was 18 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 b-TN3 Synthesis Example b-TN3

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 p-페닐렌디아민 106g(0.985몰) 및 3-(3,5-디아미노벤조일옥시)콜레스탄 7.8g(0.015몰)을 N-메틸-2-피롤리돈 3,042g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산을 함유하는 용액을 얻었다. 여기에서 얻어진 폴리암산 용액의 용액 점도는 181mPa·s였다. 224 g (1.0 mole) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydride, 106 g (0.985 mole) of p-phenylenediamine as a diamine and 3- (3,5-diaminobenzoyloxy) 7.8 g (0.015 mol) of cholestane was dissolved in 3,042 g of N-methyl-2-pyrrolidone, and the reaction was carried out at 60 DEG C for 6 hours to obtain a solution containing polyamic acid. The solution viscosity of the obtained polyamic acid solution was 181 mPa · s.

얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,380g을 추가하고, 피리딘 395g 및 무수 아세트산 306g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 γ-부티로락톤으로 용매 치환하고, 추가로 농축함으로써, 이미드화율 약 95%의 폴리이미드(b-TN3)를 10중량% 함유하는 용액을 얻었다. To the obtained polyamic acid solution, 3,380 g of N-methyl-2-pyrrolidone was added, and 395 g of pyridine and 306 g of acetic anhydride were added and the dehydration ring-closure reaction was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a solvent with fresh? -Butyrolactone and further concentrated to obtain a solution containing 10% by weight of polyimide (b-TN3) having an imidization rate of about 95%.

이 용액을 소량 분취하여, γ-부티로락톤을 더하여 농도 6중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. A small amount of this solution was fractionated and? -Butyrolactone was added thereto to prepare a solution having a concentration of 6% by weight. The viscosity of the solution was 35 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

<VA형 액정 배향제용 중합체의 합성 및 안정성 평가> &Lt; Synthesis and Stability Evaluation of Polymer for VA Type Liquid Crystal Aligner &

[특정 중합체로서의 폴리이미드의 합성예] [Example of synthesis of polyimide as specific polymer]

합성예 B-VA1Synthesis Example B-VA1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.1몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.1몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 79mPa·s였다. 112 g (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydrides, 49 g (0.1 mol) of cholestanyloxy-2,4-diaminobenzene and 87 g (0.80 mol) of p-phenylenediamine were dissolved in N-methyl-2-pyrrolidone And the reaction was carried out at 60 DEG C for 6 hours to obtain a polyamic acid solution. A small amount of the resulting polyamic acid solution was collected and added with N-methyl-2-pyrrolidone to obtain a solution having a polymer concentration of 10 wt%, and the solution viscosity was 79 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 51%의 폴리이미드(B-VA1)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 102mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the resulting polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration cyclization reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA1) having an imidization rate of about 51%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyimide concentration of 10% by weight, and the solution viscosity was 102 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-VA2 Synthesis Example B-VA2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.1몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.1몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 71mPa·s였다. 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydrides, 49 g (0.1 mol) of cholestanyloxy-2,4-diaminobenzene and 87 g (0.80 mol) of p-phenylenediamine were dissolved in N-methyl-2-pyrrolidone And the reaction was carried out at 60 DEG C for 6 hours to obtain a polyamic acid solution. A small amount of the obtained polyamic acid solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polymer concentration of 10 wt%, and the solution viscosity was 71 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 48%의 폴리이미드(B-VA2)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 99mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the resulting polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA2) having an imidization rate of about 48%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polyimide concentration of 10% by weight, and the solution viscosity was 99 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-VA3 Synthesis Example B-VA3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 180g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,663g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 59mPa·s였다. 45 g (0.20 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 180 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic acid dianhydride, 105 g (0.20 mol) of 5-diaminobenzoic acid cholestanyl and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,663 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours to obtain poly An acid solution was obtained. A small amount of the obtained polyamic acid solution was added to N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10% by weight, and the solution viscosity was 59 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,861g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 47%의 폴리이미드(B-VA3)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 80mPa·s였다. Then, 3,861 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration cyclization was carried out at 110 DEG C for 4 hours. After the dehydration cyclization reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA3) having an imidization rate of about 47%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 80 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-VA4 Synthesis Example B-VA4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 180g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,663g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 66mPa·s였다. 45 g (0.20 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 180 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydrides, 105 g (0.20 mol) of 5-diaminobenzoic acid cholestanyl and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,663 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours to obtain poly An acid solution was obtained. A small amount of the obtained polyamic acid solution was collected and added with N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10% by weight, and the solution viscosity was 66 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,861g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 50%의 폴리이미드(B-VA4)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 89mPa·s였다. Then, 3,861 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration cyclization was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of a polyimide (B-VA4) having an imidation rate of 50%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added thereto to obtain a solution having a polyimide concentration of 10% by weight, and the solution viscosity was 89 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-VA5 Synthesis Example B-VA5

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 135g(0.60몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 90g(0.40몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰), p-페닐렌디아민 65g(0.60몰) 및 3,5-디아미노벤조산 30g(0.20몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 50mPa·s였다. 135 g (0.60 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 90 g (0.40 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydrides, (0.20 mol) of 5-diaminobenzoic acid cholestanyl, 65 g (0.60 mol) of p-phenylenediamine and 30 g (0.20 mol) of 3,5-diaminobenzoic acid were dissolved in 1,697 g of N-methyl- And the reaction was carried out at 60 DEG C for 6 hours to obtain a polyamic acid solution. A small amount of the resulting polyamic acid solution was collected and added with N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10% by weight, and the solution viscosity was 50 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 66%의 폴리이미드(B-VA5)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 79mPa·s였다. Next, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added and the dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA5) having an imidization rate of about 66%. A small amount of the polyimide solution thus obtained was added to N-methyl-2-pyrrolidone to prepare a solution having a polyimide concentration of 10% by weight, and the solution viscosity was 79 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-VA6 Synthesis Example B-VA6

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 179g(0.80몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 131g(0.25몰), p-페닐렌디아민 53g(0.50몰) 및 3,5-디아미노벤조산 38g(0.25몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 58mPa·s였다. 45 g (0.20 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 179 g (0.80 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydrides, (0.25 mol) of 5-diaminobenzoic acid cholestanyl, 53 g (0.50 mol) of p-phenylenediamine and 38 g (0.25 mol) of 3,5-diaminobenzoic acid were dissolved in 1,697 g of N-methyl- And the reaction was carried out at 60 DEG C for 6 hours to obtain a polyamic acid solution. A small amount of the obtained polyamic acid solution was added to N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10 wt%, and the solution viscosity was 58 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 69%의 폴리이미드(B-VA6)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 81mPa·s였다. Next, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added and the dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration cyclization reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (B-VA6) having an imidization rate of about 69%. A small amount of the polyimide solution thus obtained was added to N-methyl-2-pyrrolidone to prepare a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 81 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-VA7 Synthesis Example b-VA7

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 52g(0.10몰), 콜레스타닐옥시-2,4-디아미노벤젠 49g(0.10몰) 및 p-페닐렌디아민 87g(0.80몰)을 N-메틸-2-피롤리돈 1,652g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 70mPa·s였다. 224 g (1.0 mole) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic acid dianhydride, 52 g (0.10 mole) of 3,5-diaminobenzoic acid cholestanil as a diamine, 49 g (0.10 mol) of 4-diaminobenzene and 87 g (0.80 mol) of p-phenylenediamine were dissolved in 1,652 g of N-methyl-2-pyrrolidone and reacted at 60 DEG C for 6 hours to give a polyamic acid solution . A small amount of the obtained polyamic acid solution was added to N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10% by weight, and the solution viscosity was 70 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,835g을 추가하고, 피리딘 79g 및 무수 아세트산 102g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 49%의 폴리이미드(b-VA7)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 80mPa·s였다. Subsequently, 3,835 g of N-methyl-2-pyrrolidone was added to the resulting polyamic acid solution, 79 g of pyridine and 102 g of acetic anhydride were added, and dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (b-VA7) having an imidization rate of about 49%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 80 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 b-VA8 Synthesis Example b-VA8

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 224g(1.0몰) 그리고 디아민으로서 3,5-디아미노벤조산 콜레스타닐 105g(0.20몰), p-페닐렌디아민 65g(0.60몰) 및 3,5-디아미노벤조산 30g(0.20몰)을 N-메틸-2-피롤리돈 1,697g에 용해하여, 60℃에서 6시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 50mPa·s였다. 224 g (1.0 mole) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydride, 105 g (0.20 mole) of 3,5-diaminobenzoic acid cholestanil as diamine and 65 g 0.60 mole) and 30 g (0.20 mole) of 3,5-diaminobenzoic acid were dissolved in 1,697 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours to obtain a polyamic acid solution. A small amount of the resulting polyamic acid solution was collected and added with N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10% by weight, and the solution viscosity was 50 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 3,939g을 추가하고, 피리딘 119g 및 무수 아세트산 153g을 첨가하여 110℃에서 4시간 탈수 폐환을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 새로운 N-메틸-2-피롤리돈으로 용매 치환함으로써, 이미드화율 약 67%의 폴리이미드(b-VA8)를 약 15중량% 함유하는 용액을 얻었다. 얻어진 폴리이미드 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 73mPa·s였다. Next, 3,939 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 119 g of pyridine and 153 g of acetic anhydride were added and the dehydration ring closure was carried out at 110 DEG C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with fresh N-methyl-2-pyrrolidone to obtain a solution containing about 15% by weight of polyimide (b-VA8) having an imidization rate of about 67%. A small amount of the obtained polyimide solution was collected and N-methyl-2-pyrrolidone was added thereto to obtain a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 73 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

<IPS형 액정 배향제용 중합체의 합성 및 안정성 평가> <Synthesis and Stability Evaluation of Polymer for IPS Type Liquid Crystal Aligner>

[특정 중합체로서의 폴리암산의 합성예] [Example of synthesis of polyamic acid as a specific polymer]

합성예 A-IPS1 Synthesis Example A-IPS1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 45g(0.20몰) 및 피로멜리트산 2무수물 174g(0.80몰) 그리고 디아민으로서 p-페닐렌디아민 108g(1.0몰)을 N-메틸-2-피롤리돈 1,900g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS1)을 15중량% 함유하는 용액을 얻었다. 45 g (0.20 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 174 g (0.80 mol) of pyromellitic dianhydride as tetracarboxylic dianhydrides and 108 g (1.0 mol) of p- Was dissolved in 1,900 g of N-methyl-2-pyrrolidone and reacted at 40 占 폚 for 3 hours to obtain a solution containing 15% by weight of polyamic acid (A-IPS1).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 75mPa·s였다. A small amount of this solution was fractionated and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 75 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-IPS2 Synthesis Example a-IPS2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 190g(0.85몰) 및 피로멜리트산 2무수물 33g(0.15몰)을 이용한 것 이외는, 합성예 A-IPS1과 동일하게 하여 폴리암산(a-IPS2)을 15중량% 함유하는 용액을 얻었다. Was the same as that of Synthesis Example A-IPS1 except that 190 g (0.85 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 33 g (0.15 mol) of pyromellitic dianhydride were used as the tetracarboxylic acid dianhydride. To obtain a solution containing 15 wt% of polyamic acid (a-IPS2).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 63mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 63 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화가 보여져, 보존 안정성은 불량했다. When this polymer solution was allowed to stand at 20 占 폚 for 3 days, gelation was observed and storage stability was poor.

이 폴리암산(a-IPS2)에 대해서는, 나머지 평가를 행하지 않았다. The evaluation of the polyamic acid (a-IPS2) was not performed.

[특정 중합체로서의 폴리암산의 합성예] [Example of synthesis of polyamic acid as a specific polymer]

합성예 A-IPS3 Synthesis Example A-IPS3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 110g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS3)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride as tetracarboxylic dianhydrides and 4,4'-diaminodiphenyl ether (A-IPS3) was obtained by dissolving 160 g (0.80 mol) of p-phenylenediamine and 110 g (0.20 mol) of p-phenylenediamine in 2,300 g of N-methyl- 15% by weight.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 74mPa·s였다. A small amount of this solution was collected and added to N-methyl-2-pyrrolidone to give a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 74 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 A-IPS4 Synthesis Example A-IPS4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰)을 이용한 것 이외는 합성예 A-IPS3과 동일하게 하여 폴리암산(A-IPS4)을 15중량% 함유하는 용액을 얻었다. As in Synthesis Example A-IPS3 except that 180 g (0.80 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride were used as the tetracarboxylic acid dianhydride To obtain a solution containing 15 wt% of polyamic acid (A-IPS4).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 60mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added thereto to prepare a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 60 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 A-IPS5 Synthesis Example A-IPS5

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐아민 200g(1.0몰)을 N-메틸-2-피롤리돈 2,400g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(A-IPS5)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride as tetracarboxylic dianhydrides and 4,4'-diaminodiphenylamine (1.0 mole) was dissolved in 2,400 g of N-methyl-2-pyrrolidone and the reaction was carried out at 40 占 폚 for 3 hours to obtain a solution containing 15 mass% of polyamic acid (A-IPS5).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 65mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 65 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 A-IPS6 Synthesis Example A-IPS6

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 180g(0.80몰) 및 피로멜리트산 2무수물 44g(0.20몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 100g(0.50몰) 및 4,4'-디아미노디페닐아민 100g(0.50몰)을 각각 이용한 것 이외는 합성예 A-IPS5와 동일하게 하여 폴리암산(A-IPS6)을 15중량% 함유하는 용액을 얻었다. 180 g (0.80 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 44 g (0.20 mol) of pyromellitic dianhydride as tetracarboxylic dianhydrides and 4,4'-diaminodiphenyl ether Except that 100 g (0.50 mole) of 4,4'-diaminodiphenylamine and 100 g (0.50 mole) of 4,4'-diaminodiphenylamine were respectively used in the same manner as in Synthesis Example A-IPS5 &Lt; / RTI &gt;

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 70mPa·s였다. A small amount of this solution was collected and added with N-methyl-2-pyrrolidone to give a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 70 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리암산의 합성예] [Synthesis example of other polyamic acid]

합성예 a-IPS7 Synthesis Example a-IPS7

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 224g(1.0몰) 그리고 디아민으로서 p-페닐렌디아민 108g(1.0몰)을 N-메틸-2-피롤리돈 1,900g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS7)을 15중량% 함유하는 용액을 얻었다. 224 g (1.0 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride as tetracarboxylic dianhydride and 108 g (1.0 mol) of p-phenylenediamine as diamine were dissolved in N-methyl-2-pyrrolidone 1,900 g, and the reaction was carried out at 40 占 폚 for 3 hours to obtain a solution containing 15 wt% of polyamic acid (a-IPS7).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 99mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a polyamic acid concentration of 10% by weight, and the solution viscosity was 99 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화가 관찰되어, 보존 안정성은 불량했다. When this polymer solution was allowed to stand at 20 占 폚 for 3 days, gelation was observed and storage stability was poor.

이 폴리암산(a-IPS7)에 대해서는, 나머지 평가를 행하지 않았다. The evaluation of the polyamic acid (a-IPS7) was not performed.

합성예 a-IPS8 Synthesis Example a-IPS8

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 224g(1.0몰)을 이용한 것 이외는 합성예 A-IPS5와 동일하게 하여 폴리암산(a-IPS8)을 15중량% 함유하는 용액을 얻었다. (A-IPS8) was polymerized in the same manner as in Synthesis Example A-IPS5 except that 224 g (1.0 mole) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic acid dianhydride was used as the tetracarboxylic acid dianhydride. % Solution.

이 용액은, 반응 온도(40℃)에서 용액 형상이었지만, 이것을 실온까지 냉각하는 과정에서 겔화가 발생했기 때문에, 점도를 측정할 수 없었다. This solution was in the form of a solution at the reaction temperature (40 ° C), but since the gelation occurred during cooling to room temperature, the viscosity could not be measured.

이 폴리암산(a-IPS8)에 대해서는, 나머지 평가를 행하지 않았다. The evaluation of the polyamic acid (a-IPS8) was not performed.

합성예 a-IPS9 Synthesis Example a-IPS9

테트라카본산 2무수물로서 피로멜리트산 2무수물 220g(1.0몰) 및 디아민으로서 p-페닐렌디아민 110g(1.0몰)을 N-메틸-2-피롤리돈 1,800g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS9)을 15중량% 함유하는 용액을 얻었다. 220 g (1.0 mole) of pyromellitic dianhydride as tetracarboxylic acid dianhydride and 110 g (1.0 mole) of p-phenylenediamine as a diamine were dissolved in 1,800 g of N-methyl-2-pyrrolidone, The reaction was carried out to obtain a solution containing 15 wt% of polyamic acid (a-IPS9).

이 용액의 용액 점도는 180mPa·s였다. The solution viscosity of this solution was 180 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 a-IPS10 Synthesis Example a-IPS10

테트라카본산 2무수물로서 피로멜리트산 2무수물 220g(1.0몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 22g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS10)을 15중량% 함유하는 용액을 얻었다. 220 g (1.0 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride, 160 g (0.80 mol) of 4,4'-diaminodiphenyl ether as diamine and 22 g (0.20 mol) of p- Was dissolved in 2,300 g of 2-pyrrolidone and reacted at 40 占 폚 for 3 hours to obtain a solution containing 15 mass% of polyamic acid (a-IPS10).

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 71mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polyamic acid concentration of 10 wt%, and the solution viscosity was 71 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 a-IPS11 Synthesis Example a-IPS11

테트라카본산 2무수물로서 피로멜리트산 2무수물 200g(0.90몰) 및 1,2,3,4-사이클로부탄테트라카본산 2무수물 20g(0.10몰) 그리고 디아민으로서 4,4'-디아미노디페닐에테르 160g(0.80몰) 및 p-페닐렌디아민 22g(0.20몰)을 N-메틸-2-피롤리돈 2,300g에 용해하여, 40℃에서 3시간 반응을 행함으로써, 폴리암산(a-IPS11)을 15중량% 함유하는 용액을 얻었다. 200 g (0.90 mol) of pyromellitic dianhydride as tetracarboxylic dianhydride, 20 g (0.10 mol) of 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 4,4'-diaminodiphenyl ether as a diamine Methyl-2-pyrrolidone was dissolved in 2,300 g of N-methyl-2-pyrrolidone and the reaction was carried out at 40 占 폚 for 3 hours to obtain polyamic acid (a-IPS11) 15% by weight.

이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 폴리암산 농도 10중량%의 용액으로 하여 측정한 용액 점도는 77mPa·s였다. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added thereto to give a solution having a concentration of 10% by weight of polyamic acid. The viscosity of the solution was 77 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[특정 중합체로서의 폴리이미드의 합성예] [Example of synthesis of polyimide as specific polymer]

합성예 B-IPS1 Synthesis Example B-IPS1

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 86g(0.80몰), 4,4'-디아미노디페닐메탄 23g(0.10몰) 및 4,4'-비스(트리플루오로메틸)비페닐 32g(0.10몰)을 N-메틸-2-피롤리돈 2,100g에 용해하여, 40℃에서 3시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여, 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 40mPa·s였다. (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic acid dianhydride, and p- (0.10 mol) of 4,4'-diaminodiphenylmethane and 32 g (0.10 mol) of 4,4'-bis (trifluoromethyl) biphenyl were dissolved in N, N-dimethylformamide -Pyrrolidone, and the reaction was carried out at 40 DEG C for 3 hours to obtain a polyamic acid solution. A small amount of the obtained polyamic acid solution was added to N-methyl-2-pyrrolidone to prepare a solution having a polymer concentration of 10 wt%, and the solution viscosity was 40 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,800g을 추가하고, 피리딘 400g 및 무수 아세트산 310g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 92%의 폴리이미드(B-IPS1)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 36mPa·s였다. Then, 2,800 g of N-methyl-2-pyrrolidone was added to the resulting polyamic acid solution, and 400 g of pyridine and 310 g of acetic anhydride were added and the dehydration ring-closure reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with γ-butyrolactone by solvent and then concentrated to obtain 2,300 g of a solution containing 15% by weight of polyimide (B-IPS1) having an imidization rate of about 92%. A small amount of this solution was fractionated and? -Butyrolactone was added to obtain a solution having a polyimide concentration of 10 wt%, and the viscosity of the solution was found to be 36 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-IPS2 Synthesis Example B-IPS2

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰)을 이용한 것 이외는 합성예 B-IPS1과 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. Except that 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride were used as the tetracarboxylic acid dianhydride A polyamic acid solution was obtained in the same manner as in Synthesis Example B-IPS1. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polymer concentration of 10% by weight, and the solution viscosity was 35 mPa · s.

이어서, 합성예 B-IPS1과 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 94%의 폴리이미드(B-IPS2)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 34mPa·s였다. Subsequently, the dehydration ring closure reaction was carried out in the same manner as in Synthesis Example B-IPS1, the solvent in the system was replaced with γ-butyrolactone by solvent and then concentrated to obtain a polyimide (B-IPS2) having an imidization rate of about 94% 15% by weight. A small amount of this solution was fractionated and? -Butyrolactone was added to obtain a solution having a polyimide concentration of 10 wt%, and the viscosity of the solution was found to be 34 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-IPS3 Synthesis Example B-IPS3

테트라카본산 2무수물로서 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰) 그리고 디아민으로서 p-페닐렌디아민 97g(0.90몰) 및 4,4'-비스(트리플루오로메틸) 비페닐 32g(0.10몰)을 N-메틸-2-피롤리돈 2,000g에 용해하여, 40℃에서 3시간 반응을 행하여, 폴리암산 용액을 얻었다. 얻어진 폴리암산 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 46mPa·s였다. (0.50 mol) of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic acid dianhydride, and p- (0.90 mol) of phenylenediamine and 32 g (0.10 mol) of 4,4'-bis (trifluoromethyl) biphenyl were dissolved in 2,000 g of N-methyl-2-pyrrolidone and reacted at 40 ° C for 3 hours To obtain a polyamic acid solution. A small amount of the obtained polyamic acid solution was collected and N-methyl-2-pyrrolidone was added thereto to obtain a solution having a polymer concentration of 10% by weight, and the solution viscosity was 46 mPa · s.

이어서, 얻어진 폴리암산 용액에 N-메틸-2-피롤리돈 2,700g을 추가하고, 피리딘 400g 및 무수 아세트산 310g을 첨가하여 110℃에서 4시간 탈수 폐환 반응을 행했다. 탈수 폐환 반응 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(B-IPS3)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 42mPa·s였다. Next, 2,700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, 400 g of pyridine and 310 g of acetic anhydride were added and the dehydration ring-closure reaction was carried out at 110 DEG C for 4 hours. After the dehydration cyclization reaction, the solvent in the system was replaced with γ-butyrolactone by solvent and then concentrated to obtain 2,300 g of a solution containing 15% by weight of polyimide (B-IPS3) having an imidization rate of about 93%. A small amount of this solution was fractionated and? -Butyrolactone was added thereto to obtain a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 42 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 B-IPS4 Synthesis Example B-IPS4

테트라카본산 2무수물로서 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물 112g(0.50몰) 및 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 112g(0.50몰)을 이용한 것 이외는 합성예 B-IPS3과 동일하게 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 35mPa·s였다. Except that 112 g (0.50 mol) of 1R, 2S, 4S, 5R-cyclohexanetetracarboxylic dianhydride and 112 g (0.50 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride were used as the tetracarboxylic acid dianhydride Synthesis Example B-A polyamic acid solution was obtained in the same manner as in IPS-3. A small amount of this solution was collected and N-methyl-2-pyrrolidone was added to obtain a solution having a polymer concentration of 10% by weight, and the solution viscosity was 35 mPa · s.

이어서, 합성예 B-IPS3과 동일하게 하여 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 91%의 폴리이미드(B-IPS4)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 용액 점도는 33mPa·s였다. Subsequently, the dehydration ring closure reaction was carried out in the same manner as in Synthesis Example B-IPS3, the solvent in the system was replaced with γ-butyrolactone solvent and then concentrated to obtain a polyimide (B-IPS4) having an imidization rate of about 91% To obtain 2,300 g of a solution containing 15% by weight. A small amount of this solution was collected, and? -Butyrolactone was added thereto to obtain a solution having a polyimide concentration of 10 wt%, and the solution viscosity was 33 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

[기타 폴리이미드의 합성예] [Synthesis example of other polyimide]

합성예 b-IPS5 Synthesis Example b-IPS5

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 220g(1.0몰)을 이용한 것 이외는 합성예 B-IPS1과 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 48mPa·s였다. A polyamic acid solution was obtained in the same manner as in Synthesis Example B-IPS1 except that 220 g (1.0 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride was used as the tetracarboxylic acid dianhydride. A small amount of this solution was taken out and N-methyl-2-pyrrolidone was added to obtain a solution having a polymer concentration of 10% by weight, and the solution viscosity was 48 mPa · s.

이어서, 합성예 B-IPS1과 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(b-IPS5)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 45mPa·s였다. Subsequently, the dehydration ring closure reaction was carried out in the same manner as in Synthesis Example B-IPS1, the solvent in the system was replaced with gamma -butyrolactone by solvent and then concentrated to obtain a polyimide (b-IPS5) having an imidization rate of about 93% 15% by weight. A small amount of this solution was fractionated and? -Butyrolactone was added to obtain a solution having a polyimide concentration of 10 wt%, and the viscosity of the solution was found to be 45 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

합성예 b-IPS6 Synthesis Example b-IPS6

테트라카본산 2무수물로서 2,3,5-트리카복시사이클로펜틸아세트산 2무수물 220g(1.0몰)을 이용한 것 이외는 합성예 B-IPS4와 동일하게 하여 폴리암산 용액을 얻었다. 이 용액을 소량 분취하여, N-메틸-2-피롤리돈을 더하여 중합체 농도 10중량%의 용액으로 하여 측정한 용액 점도는 45mPa·s였다. A polyamic acid solution was obtained in the same manner as in Synthesis Example B-IPS4 except that 220 g (1.0 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride was used as the tetracarboxylic acid dianhydride. A small amount of this solution was collected and added with N-methyl-2-pyrrolidone to obtain a solution having a polymer concentration of 10 wt%, and the solution viscosity was 45 mPa · s.

이어서, 합성예 B-IPS4와 동일하게 탈수 폐환 반응을 행한 후, 계 내의 용매를 γ-부티로락톤으로 용매 치환하고, 이어서 농축함으로써, 이미드화율 약 93%의 폴리이미드(b-IPS6)를 15중량% 함유하는 용액 2,300g을 얻었다. 이 용액을 소량 분취하여, γ-부티로락톤을 더하여 폴리이미드 농도 10중량%의 용액으로 하여 측정한 점도는 41mPa·s였다. Subsequently, the dehydration ring closure reaction was carried out in the same manner as in Synthesis Example B-IPS4, the solvent in the system was replaced with γ-butyrolactone solvent and then concentrated to obtain a polyimide (b-IPS6) having an imidization rate of about 93% 15% by weight. A small amount of this solution was fractionated and? -Butyrolactone was added to obtain a solution having a polyimide concentration of 10 wt%, and the viscosity of the solution was found to be 41 mPa · s.

이 중합체 용액을 20℃에서 3일간 정치한 결과, 겔화되는 일 없이, 보존 안정성은 양호했다. The polymer solution was allowed to stand at 20 占 폚 for 3 days. As a result, the polymer solution was not gelated, and storage stability was good.

<TN형 액정 배향제의 조제 및 평가> <Preparation and Evaluation of TN Type Liquid Crystal Aligning Agent>

실시예 TN-1 Example TN-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

특정 중합체로서 상기 합성예 A-TN1에서 얻어진 폴리암산(A-TN1)을 함유하는 용액인 폴리암산(A-TN1)으로 환산하여 80중량부에 상당하는 양과, 기타 중합체로서 상기 합성예 b-TN2에서 얻어진 폴리이미드(b-TN2)를 함유하는 용액인 폴리이미드(b-TN2)로 환산하여 20중량부에 상당하는 양을 합하고, 이것에 N-메틸-2-피롤리돈(NMP), γ-부티로락톤(BL) 및 부틸셀로솔브(BC)를, 마지막 용매 조성이 NMP:BL:BC=17:71:12(중량비)가 되도록 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-4,4'-디아미노디페닐메탄을 2중량부를 더하여, 고형분 농도 3.5중량%의 용액을 조제했다. 이 용액을 충분히 교반 후, 공경(孔徑) 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. (A-TN1) which is a solution containing the polyamic acid (A-TN1) obtained in Synthesis Example A-TN1 as a specific polymer and the amount equivalent to 80 parts by weight in terms of polyamic acid (B-TN2) as a solution containing the polyimide (b-TN2) obtained in Example 1, and adding thereto 20 parts by weight of N-methyl-2-pyrrolidone (NMP) -Butyrolactone (BL) and butyl cellosolve (BC) were added in such a manner that the final solvent composition was NMP: BL: BC = 17: 71: 12 (weight ratio) , And N'-tetraglycidyl-4,4'-diaminodiphenyl methane were added to prepare a solution having a solid concentration of 3.5% by weight. This solution was sufficiently stirred, and then filtered using a filter having a pore diameter of 1 탆 to prepare a liquid crystal aligning agent.

(II) 액정 배향제의 평가 (II) Evaluation of liquid crystal aligning agent

(1) TN형 액정 셀의 제조 (1) Preparation of TN type liquid crystal cell

상기에서 조제한 액정 배향제를, 액정 배향막 인쇄기(니혼샤신인사츠 가부시키가이샤 제조)를 이용하여 ITO막으로 이루어지는 투명 전극 부착 유리 기판의 투명 전극면에 도포하고, 80℃의 핫플레이트 상에서 1분간 가열(프리베이킹)하여 용매를 제거한 후, 200℃의 핫플레이트 상에서 10분간 가열(포스트베이킹)하여, 평균 막두께 600Å의 도막을 형성했다. The liquid crystal aligning agent prepared above was applied to the transparent electrode surface of a glass substrate with a transparent electrode made of an ITO film using a liquid crystal alignment film printing machine (manufactured by Nihon Shinsengattsu Co., Ltd.) and heated on a hot plate at 80 캜 for 1 minute (Prebaked) to remove the solvent, and then heated (post baking) on a hot plate at 200 ° C for 10 minutes to form a coating film having an average film thickness of 600 Å.

이 도막에 대하여, 레이온 천을 감은 롤을 갖는 러빙 머신에 의해, 롤 회전수 500rpm, 스테이지 이동 속도 3cm/초, 모족(毛足) 압입 길이 0.4mm에서 러빙 처리를 행하여, 액정 배향능을 부여했다. 그 후, 초순수 중에서 1분간 초음파 세정을 행하고, 이어서 100℃ 클린 오븐 안에서 10분간 건조함으로써, 액정 배향막을 갖는 기판을 얻었다. 이 조작을 반복하여, 액정 배향막을 갖는 기판을 한 쌍(2매) 얻었다. The coating film was rubbed with a rubbing machine having a roll covered with a rayon cloth at a roll rotation speed of 500 rpm, a stage moving speed of 3 cm / sec, and a hair pressing indentation length of 0.4 mm to give a liquid crystal aligning ability. Thereafter, the substrate was ultrasonically cleaned in ultrapure water for 1 minute and then dried in a 100 ° C clean oven for 10 minutes to obtain a substrate having a liquid crystal alignment film. This operation was repeated to obtain a pair of substrates (two substrates) each having a liquid crystal alignment film.

다음으로, 상기 한 쌍의 기판 중 1매의 액정 배향막을 갖는 면의 외연(外緣)에, 직경 5.5㎛의 산화 알루미늄구 함유 에폭시 수지 접착제를 도포하고, 한 쌍의 기판을 액정 배향막면이 상대하도록 대향시켜 압착한 후, 접착제를 경화했다. 이어서, 액정 주입구로부터 한 쌍의 기판 간에, 네마틱형 액정(메르크사, MLC-6221)을 충전한 후, 아크릴계 광경화 접착제로 액정 주입구를 봉지함으로써, 액정 셀을 제조했다. Next, an epoxy resin adhesive containing aluminum oxide spheres having a diameter of 5.5 占 퐉 was applied to the outer edge of the surface having one liquid crystal alignment film among the pair of substrates, and a pair of substrates was laminated on the liquid crystal alignment film surface And then the adhesive was cured. Subsequently, a nematic liquid crystal (Merck, MLC-6221) was filled between a pair of substrates from a liquid crystal injection port, and then a liquid crystal injection hole was sealed with an acrylic photo-curable adhesive to manufacture a liquid crystal cell.

(2) 내열 안정성의 평가 (2) Evaluation of heat resistance stability

전압 보전율을 지표로 하여 열스트레스에 대한 내구성을 평가했다. 전압 보전율의 측정 장치로서는, 가부시키가이샤 토요테크니카 제조, 형식 「VHR-1」을 사용했다. The durability against thermal stress was evaluated using the voltage holding ratio as an index. As the device for measuring the voltage holding ratio, a type &quot; VHR-1 &quot; manufactured by Toyo Technica Co., Ltd. was used.

상기에서 제조한 액정 셀에 대해서, 60℃에서, 액정 표시 소자에 5V의 전압을 60마이크로초의 인가 시간, 167밀리초의 스팬으로 인가한 후, 전압 인가 해제로부터 167밀리초 후에 전압 보전율을 측정했다(초기 전압 보전율 VHR0). A voltage of 5 V was applied to the liquid crystal cell at a temperature of 60 占 폚 for an application time of 60 microseconds and a span of 167 milliseconds at a temperature of 60 占 폚 and the voltage maintenance ratio was measured 167 milliseconds after the voltage was removed Initial voltage reserve ratio VHR0).

이어서, 열스트레스 인가 전 전압 보전율 측정 후의 액정 표시 소자에 대해서, 100℃의 오븐 안에서 1,000시간 정치하여 열스트레스를 인가한 후, 상기와 동일하게 하여 재차 전압 보전율을 측정했다(열스트레스 인가 후 전압 보전율 VHR1). Subsequently, the liquid crystal display element after the measurement of the voltage stress compensation applied voltage was held for 1,000 hours in an oven at 100 deg. C to apply thermal stress, and then the voltage maintenance ratio was measured again in the same manner as described above VHR1).

상기에서 측정한 VHR0 및 VHR1의 값을 이용하여, 하기 수식 (1): Using the values of VHR0 and VHR1 measured above, the following formula (1):

ΔVHR=VHR0-VHR1 (1) VHR = VHR0 - VHR1 (1)

에 의해 열스트레스 인가 전후의 전압 보전율의 차이 △VHR을 구했다. 이 값이 5% 이내인 경우, 내열 안정성은 양호하다고 평가할 수 있다. The difference ΔVHR between the voltages before and after the application of the thermal stress was obtained. When this value is within 5%, it can be evaluated that the heat stability is good.

평가 결과는 표 1에 나타냈다. The evaluation results are shown in Table 1.

실시예 TN-2 및 TN-3 그리고 비교예 tn-1 및 tn-2 Examples TN-2 and TN-3 and comparative examples tn-1 and tn-2

상기 실시예 TN-1에 있어서, 특정 중합체 및 기타 중합체로서, 각각 표 1에 기재된 종류 및 양의 중합체를 함유하는 용액을 사용하고, 각 용매를 마지막 용매 조성이 표 1에 기재한 바와 같이 되도록 더한 것 외는 실시예 TN-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In the above Example TN-1, as the specific polymer and the other polymer, a solution containing a polymer of the kind and amount described in Table 1 was used, and each solvent was added so that the final solvent composition was as shown in Table 1 A liquid crystal aligning agent was prepared and evaluated in the same manner as in Example TN-1.

평가 결과는 표 1에 나타냈다. The evaluation results are shown in Table 1.

표 1 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. 비교예 tn-1에서는, 기타 중합체로서 2종의 중합체를 혼합 사용했다. "-" in Table 1 indicates that the polymer corresponding to the column was not used. In Comparative Example tn-1, two polymers were mixed and used as the other polymer.

표 1에 있어서의 용매의 약칭은, 각각 이하의 의미이다. The abbreviations of the solvents in Table 1 are as follows.

NMP: N-메틸-2-피롤리돈 NMP: N-methyl-2-pyrrolidone

BL: γ-부티로락톤 BL:? -Butyrolactone

BC: 부틸셀로솔브 BC: butyl cellosolve

Figure 112011002929345-pat00003
Figure 112011002929345-pat00003

<VA형 액정 배향제의 조제 및 평가> &Lt; Preparation and evaluation of VA type liquid crystal aligning agent >

실시예 VA-1 Example VA-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

중합체로서, 상기 합성예 B-VA1에서 얻어진 폴리이미드(B-VA1)를 함유하는 용액에 N-메틸-2-피롤리돈 및 부틸셀로솔브를 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-m-자일렌디아민을, 사용한 폴리이미드 100중량부에 대하여 5중량부 더하고 충분히 교반하여, 용매 조성이 N-메틸-2-피롤리돈:부틸셀로솔브=50:50(중량비), 고형분 농도 3.5중량%의 용액으로 했다. 이 용액을 공경 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. N-methyl-2-pyrrolidone and butyl cellosolve were added to a solution containing the polyimide (B-VA1) obtained in Synthesis Example B-VA1 as a polymer, and N, N, N ', N'-tetraglycidyl-m-xylylenediamine was added in an amount of 5 parts by weight based on 100 parts by weight of the polyimide used and sufficiently stirred to obtain a solution having a solvent composition of N-methyl-2-pyrrolidone: butyl cellosolve = 50: 50 (weight ratio), and a solid content concentration of 3.5% by weight. This solution was filtered using a filter having a pore size of 1 탆 to prepare a liquid crystal aligning agent.

(II) 액정 배향제의 평가 (II) Evaluation of liquid crystal aligning agent

(1) VA형 액정 셀의 제조 (1) Production of VA type liquid crystal cell

두께 1mm의 유리 기판의 편면에 형성된 ITO막으로 이루어지는 투명 도전막 상에, 상기에서 조제한 액정 배향제를 스피너에 의해 도포하고, 핫플레이트 상 80℃에서 1분간의 프리베이킹을 행하고, 이어서 핫플레이트 상 210℃에서 30분간 포스트베이킹함으로써, 막두께 80nm의 도막(액정 배향막)을 형성했다. 이 조작을 반복하여, 액정 배향막을 갖는 기판을 2매(한 쌍) 얻었다. The liquid crystal aligning agent prepared above was applied on a transparent conductive film made of an ITO film formed on one side of a glass substrate having a thickness of 1 mm by a spinner and prebaked on a hot plate at 80 DEG C for 1 minute, Followed by post-baking at 210 占 폚 for 30 minutes to form a coating film (liquid crystal alignment film) having a thickness of 80 nm. This operation was repeated to obtain two substrates (one pair) each having a liquid crystal alignment film.

다음으로, 상기 한 쌍의 기판 중 1매의 액정 배향막을 갖는 면의 외연에, 직경 3.5um의 산화 알루미늄구 함유 에폭시 수지 접착제를 도포하고, 한 쌍의 기판을 각 액정 배향막이 상대하도록 대향시켜 압착한 후, 접착제를 경화했다. 이어서, 액정 주입구로부터 기판 간에, 네거티브형 액정(메르크사 제조, MLC-6608)을 충전한 후, 아크릴계 광경화 접착제로 액정 주입구를 봉지하여, 액정 셀을 제조했다. Next, an epoxy resin adhesive containing aluminum oxide spheres having a diameter of 3.5 탆 was applied to the outer edge of the surface having one liquid crystal alignment film among the pair of substrates, and the pair of substrates were opposed to each other so that the liquid crystal alignment films opposed to each other, After that, the adhesive was cured. Subsequently, a negative-type liquid crystal (MLC-6608, manufactured by Merck Ltd.) was charged between the substrates from the liquid crystal injection port, and then a liquid crystal injection hole was sealed with an acrylic-based photo-curable adhesive to produce a liquid crystal cell.

(2) 내열 안정성의 평가 (2) Evaluation of heat resistance stability

상기에서 제조한 액정 셀을 이용하여, 상기 실시예 TN-1과 동일하게 하여 내열 안정성의 평가를 했다. 단, VA형의 액정 셀의 경우, 열스트레스 인가 전후의 전압 보전율의 차이 △VHR의 값이 2% 이내인 경우에 내열 안정성은 양호하다고 평가할 수 있다. Using the liquid crystal cell prepared above, thermal stability was evaluated in the same manner as in Example TN-1. However, in the case of the VA type liquid crystal cell, it can be evaluated that the heat stability is good when the value of the difference ΔVHR between before and after the application of heat stress is within 2%.

평가 결과는 표 2에 나타냈다. The evaluation results are shown in Table 2.

실시예 VA-2∼VA-6 그리고 비교예 va-1 및 va-2 Examples VA-2 to VA-6 and Comparative Examples va-1 and va-2

상기 실시예 VA-1에 있어서, 중합체로서 각각 표 2에 기재된 중합체를 함유하는 용액을 사용한 것 외는 실시예 VA-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. A liquid crystal aligning agent was prepared and evaluated in the same manner as in Example VA-1 except that a solution containing the polymer shown in Table 2 was used as the polymer in Example VA-1.

평가 결과는 표 2에 나타냈다. The evaluation results are shown in Table 2.

표 2 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. &Quot; - &quot; in Table 2 indicates that the polymer corresponding to the column was not used.

표 2에 있어서의 용매의 약칭은, 표 1의 경우와 동일하다. The abbreviations of the solvents in Table 2 are the same as those in Table 1.

Figure 112011002929345-pat00004
Figure 112011002929345-pat00004

<IPS형 액정 배향제의 조제 및 평가> &Lt; Preparation and evaluation of IPS liquid crystal aligning agent >

실시예 IPS-1 Example IPS-1

(I) 액정 배향제의 조제 (I) Preparation of liquid crystal aligning agent

중합체로서 상기 합성예 A-IPS1에서 얻어진 폴리암산(A-IPS1)을 함유하는 용액에 용매로서, N-메틸-2-피롤리돈 및 부틸셀로솔브를 더하고, 추가로 에폭시 화합물로서 N,N,N',N'-테트라글리시딜-m-자일렌디아민을, 사용한 폴리암산 100중량부에 대하여 5중량부 더하여 충분히 교반하여, 용매 조성이 N-메틸-2-피롤리돈:부틸셀로솔브=80:20(중량비), 고형분 농도 3.5중량%의 용액으로 했다. 이 용액을 공경 1㎛의 필터를 이용하여 여과함으로써, 액정 배향제를 조제했다. N-methyl-2-pyrrolidone and butyl cellosolve were added as a solvent to the solution containing the polyamic acid (A-IPS1) obtained in Synthesis Example A-IPS1 as a polymer, and N, N And N ', N'-tetraglycidyl-m-xylylenediamine were added to 100 parts by weight of the polyamic acid used, and the mixture was thoroughly stirred to prepare a solution having a solvent composition of N-methyl-2-pyrrolidone: butyl cell Rosorb = 80: 20 (weight ratio), and a solid content concentration of 3.5% by weight. This solution was filtered using a filter having a pore size of 1 탆 to prepare a liquid crystal aligning agent.

(II) 액정 배향제의 평가 (II) Evaluation of liquid crystal aligning agent

(1) 액정 셀의 제조 (1) Production of liquid crystal cell

상기에서 조제한 액정 배향제를 이용한 것 외는 실시예 TN-1에 있어서의 것과 동일하게 하여 액정 셀을 제조하여, 내열 안정성의 평가를 행했다. A liquid crystal cell was produced in the same manner as in Example TN-1 except that the liquid crystal aligning agent prepared above was used, and the heat stability was evaluated.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

또한, 여기에서 제조한 액정 셀은 TN형 액정 셀이지만, IPS형 액정 셀의 내열 안정성 평가용 시료로서 TN형 액정 셀을 대체적(代替的)으로 이용할 수 있는 것을, 본 발명자들은 경험적으로 확인하고 있다. Further, the inventors of the present invention have experimentally confirmed that a TN liquid crystal cell produced herein can be used as a TN liquid crystal cell, but a TN liquid crystal cell can be alternatively used as a sample for evaluating the heat stability of an IPS liquid crystal cell .

실시예 IPS-2∼IPS-5 및 비교예 ips-1∼ips-3 Examples IPS-2 to IPS-5 and Comparative Examples ips-1 to ips-3

상기 실시예 IPS-1에 있어서, 중합체로서 각각 표 3에 기재된 중합체를 함유하는 용액을 사용한 것 외는 실시예 IPS-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. A liquid crystal aligning agent was prepared and evaluated in the same manner as in Example IPS-1 except that a solution containing the polymer shown in Table 3 was used as the polymer in the IPS-1.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

실시예 IPS-6∼9 그리고 비교예 ips-4 및 ips-5 Examples IPS-6 to 9 and comparative examples ips-4 and ips-5

상기 실시예 IPS-1에 있어서, 중합체로서 각각 표 3에 기재된 중합체를 함유하는 용액을, 용매로서 N-메틸-2-피롤리돈(NMP), γ-부티로락톤(BL) 및 부틸셀로솔브(BC)를 각각 사용하여, 이들 각 용매를 마지막 용매 조성이 NMP:BL:BC= 10:70:20(중량비)이 되도록 더한 것 외는, 실시예 IPS-1과 동일하게 하여 액정 배향제를 조제하여 평가했다. In Example IPS-1, a solution containing the polymer shown in Table 3 as a polymer was dissolved in N-methyl-2-pyrrolidone (NMP),? -Butyrolactone (BL) Except that each of these solvents was added so as to have a final solvent composition of NMP: BL: BC = 10: 70: 20 (weight ratio), to thereby obtain a liquid crystal aligning agent Were prepared and evaluated.

평가 결과는 표 3에 나타냈다. The evaluation results are shown in Table 3.

표 3 중의 「-」는, 당해 란에 해당하는 중합체를 사용하지 않았던 것을 나타낸다. "-" in Table 3 indicates that the polymer corresponding to the column was not used.

표 3에 있어서의 용매의 약칭은, 표 1의 경우와 동일하다. The abbreviations of the solvents in Table 3 are the same as those in Table 1.

Figure 112011002929345-pat00005
Figure 112011002929345-pat00005

Claims (6)

테트라카본산 2무수물과 디아민을 반응시켜 얻어지는 폴리암산 그리고 당해 폴리암산을 탈수 폐환하여 이루어지는 폴리이미드로 이루어지는 군으로부터 선택되는 적어도 1종의 중합체를 함유하는 액정 배향제로서,
상기 테트라카본산 2무수물이, 1S,2S,4R,5R-사이클로헥산테트라카본산 2무수물 및 1R,2S,4S,5R-사이클로헥산테트라카본산 2무수물로 이루어지는 군으로부터 선택되는 적어도 1종을, 전체 테트라카본산 2무수물에 대하여 5∼80몰% 포함하고,
상기 디아민이, 제1 디아민 20∼97몰%와 제2 디아민 3∼80몰%로 이루어지거나, 또는 제1 디아민 70∼100몰%와 제2 디아민 0∼30몰%로 이루어지고, 단, 상기 제1 디아민 및 상기 제2 디아민의 합계의 사용 비율은, 전체 디아민에 대하여 100몰%이며,
상기 제1 디아민은, p-페닐렌디아민, 3,5-디아미노벤조산, 4,4'-디아미노디페닐에테르, 4,4'-디아미노디페닐메탄, 2,2'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비페닐, 4,4'-디아미노디페닐아민 및 4,4'-(m-페닐렌디이소프로필리덴)디아닐린으로 이루어지는 군으로부터 선택되는 적어도 1종이며,
상기 제2 디아민은, 콜레스타닐옥시-3,5-디아미노벤젠, 콜레스테닐옥시-3,5-디아미노벤젠, 콜레스타닐옥시-2,4-디아미노벤젠, 콜레스테닐옥시-2,4-디아미노벤젠, 3,5-디아미노벤조산 콜레스타닐, 3,5-디아미노벤조산 콜레스테닐, 3,5-디아미노벤조산 라노스타닐, 3,6-비스(4-아미노벤조일옥시)콜레스탄, 3,6-비스(4-아미노페녹시)콜레스탄 및 하기식 (A-1)로 나타나는 화합물로 이루어지는 군으로부터 선택되는 적어도 1종
인 것을 특징으로 하는 액정 배향제:
Figure 112017062984764-pat00006

(식 (A-1) 중, XI은 탄소수 1∼3의 알킬렌기, *-O-, *-COO- 또는 *-OCO-(단, 「*」을 붙인 결합손이 디아미노페닐기와 결합함)이고, a는 0 또는 1이고, b는 0∼2의 정수이고, c는 1∼20의 정수임).
1. A liquid crystal aligning agent comprising at least one polymer selected from the group consisting of a polyamic acid obtained by reacting a tetracarboxylic acid dianhydride with a diamine and a polyimide obtained by dehydrocondylating the polyamic acid,
Wherein the tetracarboxylic acid dianhydride is at least one selected from the group consisting of 1S, 2S, 4R, 5R-cyclohexanetetracarboxylic dianhydride and 1R, 2S, 4S, 5R- cyclohexanetetracarboxylic dianhydride, Is contained in an amount of 5 to 80 mol% based on the total tetracarboxylic dianhydride,
Wherein the diamine is composed of 20 to 97 mol% of the first diamine and 3 to 80 mol% of the second diamine, or 70 to 100 mol% of the first diamine and 0 to 30 mol% of the second diamine, The total ratio of the first diamine and the second diamine is 100 mol% based on the total diamine,
The first diamine may be selected from the group consisting of p-phenylenediamine, 3,5-diaminobenzoic acid, 4,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 2,2'- , 4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 4,4'-diaminodiphenylamine and 4,4'- -Phenylene diisopropylidene) dianiline, and at least one member selected from the group consisting of
Wherein the second diamine is selected from the group consisting of cholestanyloxy-3,5-diaminobenzene, cholestenyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestenyloxy- 2,4-diaminobenzene, 3,5-diaminobenzoic acid cholestanyl, 3,5-diaminobenzoic acid cholestenyl, 3,5-diaminobenzoic acid ranostanyl, 3,6-bis Benzoyloxy) cholestane, 3,6-bis (4-aminophenoxy) cholestane and a compound represented by the following formula (A-1)
A liquid crystal aligning agent,
Figure 112017062984764-pat00006

(Wherein (A-1) of, X I is an alkylene group, having a carbon number of 1~3 * -O-, * -COO- or * -OCO- (However, the bond attached to "*" hands are engaged with diamino group A is 0 or 1, b is an integer of 0 to 2, and c is an integer of 1 to 20).
제1항에 있어서,
상기 테트라카본산 2무수물이, 1,2,3,4-사이클로부탄테트라카본산 2무수물, 2,3,5-트리카복시사이클로펜틸아세트산 2무수물, 1,3,3a,4,5,9b-헥사하이드로-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사하이드로-8-메틸-5-(테트라하이드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사바이사이클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라하이드로푸란-2',5'-디온), 5-(2,5-디옥소테트라하이드로-3-푸라닐)-3-메틸-3-사이클로헥센-1,2-디카본산 무수물, 3,5,6-트리카복시-2-카복시메틸노르보르난-2:3,5:6-2무수물, 2,4,6,8-테트라카복시바이사이클로[3.3.0]옥탄-2:4,6:8-2무수물 및 4,9-디옥사트리사이클로[5.3.1.02,6]운데칸-3,5,8,10-테트라온으로 이루어지는 군으로부터 선택되는 적어도 1종을 추가로 포함하는 것인 액정 배향제.
The method according to claim 1,
Wherein the tetracarboxylic acid dianhydride is selected from the group consisting of 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,3,3a, 4,5,9b- (Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5,9b -Hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [ 3.2.1] octane-2,4-dione-6-spiro-3 '- (tetrahydrofuran-2', 5'- dione), 5- (2,5- dioxotetrahydro- Carboxymethylnorbornane-2: 3,5: 6-2 anhydride, 2,4,6-tricarboxy-2-carboxymethylnorbornane- 6,8-tetracarboxybicyclo [3.3.0] octane-2: 4,6: 8-2 anhydride and 4,9-dioxatricyclo [5.3.1.0 2,6 ] undecane-3,5,8 , And 10-tetraene. The liquid crystal aligning agent according to claim 1, wherein the liquid crystal aligning agent further comprises at least one member selected from the group consisting of:
삭제delete 제1항 또는 제2항에 있어서,
분자 내에 적어도 1개의 에폭시기를 갖는 화합물을 추가로 함유하는 액정 배향제.
3. The method according to claim 1 or 2,
A liquid crystal aligning agent further comprising a compound having at least one epoxy group in the molecule.
제1항 또는 제2항에 기재된 액정 배향제로 형성된 것을 특징으로 하는 액정 배향막. A liquid crystal alignment film formed by the liquid crystal aligning agent according to claim 1 or 2. 제5항에 기재된 액정 배향막을 구비하는 것을 특징으로 하는 액정 표시 소자. A liquid crystal display element comprising the liquid crystal alignment film according to claim 5.
KR1020110003538A 2010-01-19 2011-01-13 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device KR101798375B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010008948 2010-01-19
JPJP-P-2010-008948 2010-01-19

Publications (2)

Publication Number Publication Date
KR20110085891A KR20110085891A (en) 2011-07-27
KR101798375B1 true KR101798375B1 (en) 2017-12-12

Family

ID=44265735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020110003538A KR101798375B1 (en) 2010-01-19 2011-01-13 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device

Country Status (4)

Country Link
JP (1) JP5849391B2 (en)
KR (1) KR101798375B1 (en)
CN (1) CN102127459B (en)
TW (1) TWI504675B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013008852A1 (en) * 2011-07-12 2013-01-17 日産化学工業株式会社 Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP5691996B2 (en) * 2011-10-21 2015-04-01 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5845918B2 (en) * 2012-01-20 2016-01-20 宇部興産株式会社 Polyimide precursor and polyimide
JP5884979B2 (en) * 2012-03-09 2016-03-15 Jsr株式会社 (1R, 2S, 4S, 5R) Method for producing cyclohexanetetracarboxylic dianhydride
KR20170061728A (en) * 2012-11-16 2017-06-05 닛산 가가쿠 고교 가부시키 가이샤 Polyimide resin film and electronic-device substrate comprising polyimide resin film
WO2014080865A1 (en) * 2012-11-21 2014-05-30 Jsr株式会社 Liquid crystal orientation agent, liquid crystal orientation membrane and method for manufacturing same, and liquid crystal display element
US20160297995A1 (en) * 2013-10-11 2016-10-13 Ube Industries, Ltd. Polyimide precursor, polyimide, polyimide film, varnish, and substrate
JP6557963B2 (en) * 2014-02-25 2019-08-14 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6596931B2 (en) * 2014-08-29 2019-10-30 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2016060213A1 (en) * 2014-10-17 2016-04-21 三菱瓦斯化学株式会社 Polyimide resin composition, polyimide film and laminate
CN111647412A (en) * 2020-06-12 2020-09-11 江苏三月科技股份有限公司 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008299318A (en) * 2007-05-02 2008-12-11 Jsr Corp Vertical alignment type liquid crystal aligning agent and liquid crystal display element
JP2009191253A (en) 2008-01-18 2009-08-27 Iwatani Industrial Gases Corp New (1s,2s,4r,5r)-cyclohexane tetracarboxylic acid dianhydride and its use
JP2009286706A (en) * 2008-05-27 2009-12-10 Iwatani Industrial Gases Corp New (1r,2s,4s,5r)-cyclohexanetetracarboxylic acid dianhydride and utilization thereof
JP2009294281A (en) 2008-06-03 2009-12-17 Jsr Corp Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238809A (en) * 1985-04-16 1986-10-24 Ube Ind Ltd Liquid photosensitive polyimide resin composition
TWI283783B (en) * 1999-12-09 2007-07-11 Jsr Corp Liquid crystal alignment film and liquid crystal display device
JP2002062537A (en) * 2000-08-21 2002-02-28 Jsr Corp Liquid crystal aligning agent for stn (supertwisted nematic) liquid crystal display element and stn liquid crystal display element
JP2002155139A (en) * 2000-11-22 2002-05-28 Hitachi Cable Ltd Solvent-soluble block polyimide composition for liquid crystal orientated film and its manufacturing method
JP4375533B2 (en) * 2003-06-26 2009-12-02 三菱瓦斯化学株式会社 Method for producing solvent-soluble polyimide
JP5077048B2 (en) * 2007-05-02 2012-11-21 Jsr株式会社 Vertical alignment type liquid crystal alignment agent
JP2008297360A (en) * 2007-05-29 2008-12-11 New Japan Chem Co Ltd Solvent-soluble polyimide resin
JP5325491B2 (en) * 2008-08-01 2013-10-23 株式会社カネカ Novel coating type optical compensation film and method for producing the same
JP2010070721A (en) * 2008-09-22 2010-04-02 Sekisui Chem Co Ltd Polyimide and method of producing the same
JP5630139B2 (en) * 2009-08-18 2014-11-26 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008299318A (en) * 2007-05-02 2008-12-11 Jsr Corp Vertical alignment type liquid crystal aligning agent and liquid crystal display element
JP2009191253A (en) 2008-01-18 2009-08-27 Iwatani Industrial Gases Corp New (1s,2s,4r,5r)-cyclohexane tetracarboxylic acid dianhydride and its use
JP2009286706A (en) * 2008-05-27 2009-12-10 Iwatani Industrial Gases Corp New (1r,2s,4s,5r)-cyclohexanetetracarboxylic acid dianhydride and utilization thereof
JP2009294281A (en) 2008-06-03 2009-12-17 Jsr Corp Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
KR20110085891A (en) 2011-07-27
TWI504675B (en) 2015-10-21
TW201132703A (en) 2011-10-01
CN102127459A (en) 2011-07-20
JP5849391B2 (en) 2016-01-27
CN102127459B (en) 2015-09-16
JP2011170321A (en) 2011-09-01

Similar Documents

Publication Publication Date Title
KR101798375B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR101980637B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device, and compound and polymer used for producing the same
JP5273357B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101796490B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device, and polyamic acid and polyimide used for producing the same
KR101923080B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5783023B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101629805B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, and polymers contained therein
KR101647292B1 (en) Liquid crystal aligning agent, liquid crystal display device, and polymers contained therein
JP5773116B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5751403B2 (en) Liquid crystal alignment agent
KR101748250B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display device
JP2015176110A (en) liquid crystal alignment agent and liquid crystal display element
KR101782514B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR20140114749A (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, polymer and compound
JP5071662B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201302861A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
JP5691996B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101746042B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device and polymer composition
KR20150086230A (en) Liquid crystal orientation agent, liquid crystal orientation membrane and method for manufacturing same, and liquid crystal display element
KR101746043B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
JP5962381B2 (en) Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element and polymer
KR101628787B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display device, and polymers contained therein
JP2011237766A (en) Liquid crystal alignment membrane forming composition, liquid crystal alignment membrane and liquid crystal display element
JP6492982B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101828824B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant